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Laverania subgenus, including the expansion of the FIKK kinases and the presence of var-like multigene
families in all Laverania species. Our analyses also identify genetic features that are unique to P.
falciparum, such as a very low within-species diversity and a complex evolutionary history of the essential
invasion genes RH5 and CyRPA. This dissertation lays the groundwork for future comparative analyses of
the Laverania subgenus including population genomic analyses of ape parasites and comparisons of P.
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ABSTRACT
COMPARATIVE GENOMICS OF APE PLASMODIUM PARASITES REVEALS KEY
EVOLUTIONARY EVENTS LEADING TO HUMAN MALARIA

African great apes are infected with at least six species of P. falciparum-like parasites,
including the direct ancestor of P. falciparum. Comparative studies of these parasites
and P. falciparum (collectively termed the Laverania subgenus) will provide insight into
the evolutionary origins of P. falciparum and identify genetic features that influence host
tropism. Here we show that ape Laverania parasites do not sperve as a recurrent source
of human malaria and use novel enrichment techniques to derive near full-length
genomes of close and distant relatives of P. falciparum. Using a combination of single
template amplification and deep sequencing, we observe no evidence of ape Laverania
infections in forest dwelling humans in Cameroon. This result supports previous findings
that ape Laverania parasites are host specific and have successfully colonized humans
only once. To understand the determinants of host specificity and identify genetic
characteristics unique to P. falciparum, we develop a novel method for selective
enrichment of Plasmodium DNA from sub-microscopically infected whole blood samples.
We use this technique to enrich for Laverania genomic DNA from chimpanzee blood
samples and assemble near full length genomes for both close (P. reichenowi) and
distant (P. gaboni) relatives of P. falciparum. Comparative analyses of these genomes to
P. falciparum identify features that are conserved across the Laverania subgenus,
including the expansion of the FIKK kinases and the presence of var-like multigene
families in all Laverania species. Our analyses also identify genetic features that are
unique to P. falciparum, such as a very low within-species diversity and a complex
v

evolutionary history of the essential invasion genes RH5 and CyRPA. This dissertation
lays the groundwork for future comparative analyses of the Laverania subgenus
including population genomic analyses of ape parasites and comparisons of P.
falciparum to its ancestor, P. praefalciparum.
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CHAPTER 1 – Malaria Parasites of the Great Apes

1.1 The Epidemiology and Biology of Malaria
Malaria, caused by parasites of the genus Plasmodium, is responsible for hundreds of
millions of cases and over 550,000 deaths each year (1). An estimated 3.3 billion people
across the globe are at risk of infection (1). The disease has a disproportion burden on
young children who account for over 78% of total malaria related deaths (1). While the
majority of malaria related deaths are caused by P. falciparum (2), the predominant
malaria species in sub-Saharan Africa, studies suggest that P. vivax, the predominant
species outside of Africa, can also cause severe disease (3). Recently, a third parasite
has emerged as a public health threat. P. knowlesi, a zoonotic parasite of macaque
origin, is now known to cause of hundreds of severe malaria cases each year (4, 5).
The lifecycle of Plasmodium parasites is complex, involving both a vertebrate
and mosquito host. The parasites, injected into the host by a mosquito vector, initially
infect hepatocytes before being released into the blood stream. There they infect
erythrocytes to initiate a cyclic blood stage infection. During this stage, some parasites
differentiate into male and female gametocytes, which are taken up by a mosquito
vector. They undergo sexual reproduction in the vector’s midgut and develop into an
ookinete, which migrates through the midgut wall and becomes an oocyst. Finally, the
oocyst develops into numerous sporozoites. These travel to the mosquito salivary glands
to be inoculated into a new vertebrate host.
While malaria infections in humans have been recognized and treated for
thousands of years, efforts to decrease the burden of disease have only been partially
successful. P. falciparum has shown the capacity to become resistant to all known
antimalarial compounds, including the current first line treatment, artemisinin (6, 7).
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Recent vaccine trials have shown some promise, however the current best candidate
yielded only a 55% decrease in clinical malaria during the first year post vaccination (8).
Thus, novel drug and vaccine development is essential to future malaria control efforts.
The identification of drug and vaccine targets in malaria has been slowed by a
number of factors. The Plasmodium proteome is highly divergent from all other
eukaryotes sequenced to date. Of the 5,777 genes in the 22.6 megabase pair P.
falciparum genome, 60% do not share sufficient homology to genes in other organisms
to allow for functional assignment (9). Moreover, genetic manipulation of Plasmodium
species is difficult and time consuming. Successful transfection of P. falciparum typically
requires months, and knockdown studies are hindered by the absence of the RNAi
pathway (10). Studies of P. vivax are nearly impossible, as the parasite cannot be
cultured in vitro (11). While recent developments in Plasmodium genetics have improved
the ability to study these parasites, more than 35% of genes of the P. falciparum
genome remain annotated as unknown function (PlasmoDB).

1.2 Plasmodium Species in African Great Apes
Plasmodium species in our closest ape relatives were first identified in the early 1900s.
In 1920, Edward Reichenow described both P. vivax-like and P. falciparum-like parasites
in chimpanzees and gorillas (12). While it was initially unclear whether these parasites
represented novel species or were the same as those in humans, they were eventually
categorized as separate species with chimpanzee and gorilla P. vivax-like parasites
denoted P. schwetzi and chimpanzee P. falciparum-like parasites denoted P. reichenowi
(the P. falciparum-like parasites from gorillas were rarely studied outside of the original
description by Reichenow). Epidemiologic studies showed that these parasites were
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widespread in Africa, identifying them in apes from Liberia and Sierra Leone in the
northwest to the lower Republic of Congo in the south and Lake Edward in the east (13).
Little data exists on the clinical course of P. schwetzi and P. reichenowi infections
in great apes. Apes naturally infected with P. schwetzi tended to have low parasitemia,
and while the parasite burden increased in splenectomized chimpanzees, there was still
no evidence for clinical symptoms in the few studies that were performed (13). Even less
data exists for P. reichenowi, although splenectomized chimpanzees with high
parasitemia infections (360,000-500,000 parasites/cu. mm blood) did have periodic
fevers of up to 103 °F (14, 15). While these results may indicate that P. reichenowi and
P. schwetzi are less likely to cause serious clinical disease in their natural hosts, it is
also possible that the infected chimpanzees had some level of naturally acquired
immunity, similar to that observed in older humans in malaria endemic areas (16), and
therefore suffered fewer symptoms than would an infant or naïve host.
Given the close evolutionary relationship between chimpanzees and humans,
and the resemblance of P. reichenowi and P. schwetzi to P. falciparum and P. vivax,
attempts to infect humans with great ape Plasmodium species were made on multiple
occasions. P. schwetzi was successfully transferred to humans, both by mosquitoes and
inoculation with infected chimpanzee blood, and produced symptomatic infections (13).
Importantly, while P. schwetzi successfully infected multiple volunteers of European
descent, it did not yield infections in the one African American tested. In humans, P.
vivax requires the Duffy antigen receptor for chemokines (DARC) to invade red blood
cells (17). A vast majority of people of West African descent carry a mutation in the
DARC promoter (the Duffy negative phenotype) which abrogates DARC expression on
red blood cells, rendering them resistant to P. vivax invasion (18). It is possible that P.
schwetzi, like P. vivax, requires DARC for red blood cell invasion and was therefore
3

unable to infect this African American volunteer who likely lacked the receptor on his/her
red blood cells.
Unlike P. schwetzi, P. reichenowi appears very host specific. Multiple attempts to
infect humans with the parasite, either by intravenous or subcutaneous injection, failed
(13). Interestingly, at least some strains of P. falciparum can produce transient
parasitemia in intact (non-splenectomized) chimpanzees and persistent parasitemia after
splenectomy (13). Together, these data suggest that, while P. falciparum-like parasites
are more host specific than those related to P. vivax, this specificity may not be complete
and is dependent on either the host, the specific parasite strain used, or a combination
of the two.

1.3 The Origin of Human Malaria
While numerous studies of great ape Plasmodium species were carried out between the
1920s and 1970s, the parasites were all but forgotten for the next 40 years. Only a
single isolate of P. reichenowi has been maintained, through cryopreservation and
passage in captive splenectomized chimpanzees at the CDC. Phylogenetic analyses
that included sequences from this isolate confirmed its close relationship to P. falciparum
and showed that the two formed a clade that is distinct from all other known Plasmodium
species (19). Given these data, researchers hypothesized that P. falciparum and P.
reichenowi represented sister lineages that had diverged and co-evolved with their
respective hosts.
Historically, two separate hypotheses were proposed for the origin of P. vivax.
The first, supported by morphological similarities between P. vivax and multiple Asian
monkey parasites, proposed that human P. vivax was initially transmitted to humans
from Asian monkeys after early humans had migrated out of Africa (20). The second
4

suggested that P. vivax had originated in Africa, where long-term selective pressures by
the parasite had led to the emergence of fixation of the Duffy negative phenotype in
West African populations (21, 22). Later molecular characterizations and phylogenetic
analyses of human P. vivax indicated that the parasite falls within the radiation of Asian
monkey Plasmodium species (23). This suggests that P. vivax emerged during or after
the divergence of the Asian monkey parasites. As Asian monkey Plasmodium species
are thought to have radiated along with their hosts in Asia (24), these phylogenetic
analyses supported the hypothesis that P. vivax had originated in Asia.
In 2009, Prugnolle and colleagues showed Plasmodium DNA could be detected
in the fecal samples of wild living chimpanzees and gorillas (25). This discovery brought
renewed life to the studies of great ape Plasmodium. As fecal detection is non-invasive,
it could be applied to wild living great ape populations where blood sampling would be
both impractical and unethical. Studies found that P. falciparum-like parasites were
widespread among all four chimpanzee subspecies and western gorillas (25-31). These
parasites were common in wild apes, with prevalence rates, estimated from feces,
surpassing 50% at some field sites (26). Parasite mitochondrial sequences also
appeared to cluster into multiple distinct lineages, suggesting that more than one
species of P. falciparum-like parasite might be present in wild ape populations (25-31).
The identification of widespread Plasmodium infections in both chimpanzees and
gorillas brought renewed interest to the question of the origins of human malaria.
Analyzing over 1,100 mitochondrial, nuclear, and apicoplast sequences from wild living
apes, our lab identified at least 9 distinct Plasmodium lineages, six of which were closely
related to P. falciparum (26). Of these six lineages, three were found only in
chimpanzees and the other three only in gorillas. Phylogenetic analyses of these species
and P. falciparum showed that all extant strains of P. falciparum formed a single
5

monophyletic lineage that emerged from within the radiation of a single gorilla parasite
species (26). These results indicated that P. falciparum emerged from gorillas, and that
all extant P. falciparum strains may have originated from a single cross-species
transmission event (26).
As the six species topology of these P. falciparum-like parasites was observed at
all analyzed loci, including those from apicoplast, mitochondrial and nuclear genes, they
have tentatively been classified as distinct species (32). The gorilla parasites, in order of
increasing evolutionary distance to P. falciparum, are termed P. praefalciparum, P.
blacklocki, and P. adleri, while the chimpanzee parasites are termed P. reichenowi, P.
billcollinsi, and P. gaboni. In recognition of their dissimilarity to other Plasmodium
species (30, 32), we refer to these six ape species and P. falciparum as the Laverania
subgenus, a term originally suggested by Bray (33).
While phylogenetic analyses showed that the predominant global lineages of P.
falciparum were derived from a single cross-species transmission event from gorillas, we
could not rule out the possibility of local transmission between apes and humans. This is
the case for HIV-1, which also originated in African great apes. While 99% of HIV-1
infections are derived from a single lineage (group M), the virus has been transmitted
from apes to humans at least three more times, giving rise to groups N, O, and P (34).
Given the close phylogenetic relationship and likely morphological similarity between
ape Laverania parasites and P. falciparum, zoonotic infections would be unlikely to be
detected in humans. In chapter 2 of this dissertation, we develop new methods to screen
for ape Laverania parasites in humans, providing the first evidence that ape Laverania
parasites are not a significant source of human malaria infections.
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1.4 Elucidating the Steps to the Emergence of P. falciparum
The zoonotic origin of P. falciparum and lack of additional cross-species transmissions of
ape Laverania parasites suggests that P. falciparum is uniquely suited to infect humans.
While targeted sequencing is useful for understanding the evolutionary history of an
organism, the identification of genetic features that are unique to P. falciparum requires
genome level analyses. The identification of six distinct P. falciparum-like species in
great apes, none of which are recurrently transmitted to humans, provides a unique
opportunity for comparative genomics. However, these studies have been hindered by a
lack of samples suitable for whole genome sequencing.
Next generation sequencing technologies have increased the pace of whole
genome sequencing by providing a rapid, high throughput, and relatively cheap method
for shotgun sequencing. In spite of this, cost effective next generation sequencing of
larger genomes still requires samples that are enriched in the DNA of the organism of
interest (35, 36). A sample consisting of only 1% Plasmodium DNA requires 100 fold
more sequencing to achieve the same depth of genome coverage as a sample
containing 100% Plasmodium DNA. This increase in sequencing requirements increases
both the upfront cost and downstream analysis time.
Previous genomic studies of Plasmodium have used a variety of methods to
enrich for Plasmodium DNA prior to high throughput sequencing. These include short
term or long term in vitro culture, purification of infected erythrocytes from fresh blood,
selective digestion of non-Plasmodium DNA, and Plasmodium DNA capture (35-38).
While we were able to obtain Laverania positive chimpanzee blood samples from a
sanctuary in Cameroon, we found the majority of these methods to be impractical given
the source, storage conditions, and parasitemia of the available samples. In chapter 3
we develop a novel method for the enrichment of Plasmodium DNA, termed selective
7

whole genome amplification (SWGA) (39), from samples containing as little as
0.00081% Plasmodium DNA. Applying this method to three chimpanzee blood samples,
we generate near full-length genomes of chimpanzee parasites that represent both close
(P. reichenowi) and distant (P. gaboni) relatives of P. falciparum. Using these genomes
we identify genetic characteristics that are shared across the Laverania subgenus, but
also features that are unique to the ancestry of P. falciparum. These findings are
discussed in chapters 3 and 4.
Selective whole genome amplification is an effective method for enrichment of
target DNA from contaminating background DNA. The method itself is simple, requiring
only a set of short primers and the phi29 DNA polymerase. SWGA relies on differences
in short DNA motif frequency between the target and background genomes, and thus
should be easily adapted to many situations (39). Prior to this dissertation, however, the
identification of SWGA primer sets was time consuming and required a large amount of
user input (39). In chapter 5 we present a program, swga, that automates the process of
designing primer sets for selective whole genome amplification. The program also
calculates a number of statistics for each primer set, allowing sets to be compared in
silico. swga is built on a modular architecture. Additional modules can be easily added to
the program as we improve our understanding of what defines a good SWGA primer set.
By increasing the speed and ease of SWGA primer design, swga will make selective
whole genome amplification accessible to a larger number of genetics and genomics
researchers.
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CHAPTER 2 - Plasmodium falciparum-like Parasites Infecting Wild African
Apes Do Not Represent a Recurrent Source of Human Malaria
Sesh A. Sundararaman, Weimin Liu, Brandon F. Keele, Gerald H. Learn, Kyle Bittinger,
Fatima Mouacha, Steve Ahuka-Mundeke, Magnus Manske, Scott Sherrill-Mix, Yingying
Li, Jordan A. Malenke, Eric Delaporte, Christian Laurent, Eitel Mpoudi Ngole, Dominic P.
Kwiatkowski, George M. Shaw, Julian C. Rayner, Martine Peeters, Paul M. Sharp,
Frederic D. Bushman, Beatrice H. Hahn

Originally published in PNAS 110 (75):7020-7025.

Supplemental data are available at
http://www.pnas.org/content/suppl/2013/04/05/1305201110.DCSupplemental/sapp.pdf

Weimin Liu, Frederic D. Bushman, Beatrice H. Hahn, and I designed the study. I
led the computational analysis of 454 sequencing data with assistance from Kyle
Bittinger and Scott Sherrill-Mix. Weimin Liu, Brandon F. Keele, Gerald H. Learn,
Paul M. Sharp, Beatrice H. Hahn, and I developed and tested the 454
amplification and sequencing protocol. Weimin Liu, Fatima Mouacha, Steve
Ahuka-Mundeke, Yingying Li, and Jordan A. Malenke generated and analyzed
PCR and SGA data. Magnus Manske, Eric Delaporte, Christian Laurent, Eitel
Mpoudi Ngole, Dominic P. Kwiatkowski and Julian C. Rayner provided reagents
and analytic tools. Weimin Liu, George M. Shaw, Julian C. Rayner, Martine
Peeters, Paul M. Sharp, Frederic D. Bushman, and I wrote the paper with
contributions from all authors.
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2.1 Abstract
Wild-living chimpanzees and gorillas harbor a multitude of Plasmodium spp., including
six of the subgenus Laverania, one of which is the progenitor of P. falciparum. Despite
the magnitude of this natural reservoir, it is unknown whether apes represent a recurrent
source of human infections. Here, we used Plasmodium species-specific PCR, single
genome amplification (SGA) and 454 sequencing to screen humans from remote areas
of Cameroon for ape Laverania infections. Among 1,403 blood samples, we found 1,000
to be positive for Plasmodium mitochondrial (mt)DNA, all of which contained human
parasites as determined by sequencing and/or restriction enzyme digestion. To exclude
low abundance infections, we subjected 514 samples to 454 sequencing, targeting a
region of the mtDNA genome that distinguishes ape from human Laverania species.
Developing algorithms capable of differentiating rare Plasmodium variants from 454
sequencing error, we identified mono- and mixed-species infections with P. falciparum,
P. malariae and/or P. ovale. However, none of the human samples contained ape
Laverania parasites, including the gorilla precursor of P. falciparum. To characterize
further the diversity of P. falciparum in Cameroon, we used SGA to amplify 3.4 kb
mtDNA fragments from 229 infected humans. Phylogenetic analysis identified 62 new
variants, all of which clustered with extant P. falciparum strains, providing further
evidence that P. falciparum emerged following a single gorilla-to-human transmission.
Thus, unlike P. knowlesi infected macaques in Southeast Asia, African apes harboring
Laverania parasites do not serve as a recurrent source of human malaria, a finding of
import to ongoing control and eradication measures.
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2.2 Introduction
Malaria is one of the most devastating infectious diseases of humans worldwide, with
hundreds of millions of cases of clinical illness and over 650,000 deaths occurring
annually (40). Given this enormous health burden, efforts to control and potentially
eradicate this disease have become an urgent public health priority (41, 42). Effective
control and elimination measures require a clear understanding of the parasites, vectors
as well as human and environmental factors that sustain malaria transmission. This
includes a systematic evaluation of potential zoonotic reservoirs and the risk that they
may pose for humans. Recently, close genetic relatives of the human malaria parasites
P. falciparum, P. ovale, P. malariae and P. vivax have been identified in wild-living apes
in sub-Saharan Africa (25-27, 29, 30). These parasites have been tentatively classified
on the basis of their sequence relationships into a number of different species, six of
which were closely related to human P. falciparum and placed into a separate
Plasmodium subgenus, termed Laverania (26, 30-32). Of these six Laverania species,
P. reichenowi, P. gaboni, and P. billcollinsi were identified only in chimpanzees, while P.
adleri, P. blacklocki, and P. praefalciparum were only found in gorillas. Moreover, P.
praefalciparum was shown to be the immediate precursor of human P. falciparum (26).
Although the Anopheles vectors that transmit these ape parasites have not yet been
identified, the fact that a large fraction of wild-living apes is endemically infected has
raised concerns that they might represent a source of recurring human infection (25, 32,
43, 44).
In this study, we tested humans who live in remote rural areas of southern Cameroon for
evidence of zoonotic Plasmodium infections. We specifically screened for Laverania
infections, since these are the most abundant and widespread in resident ape
populations, and since one of them, P. praefalciparum, has crossed the species barrier
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from gorillas to humans already once (26). Moreover, Laverania parasites have been
studied extensively at the molecular level, with numerous mitochondrial, apicoplast and
nuclear sequences available for analyses. To detect zoonotic infections, we developed a
new ape Plasmodium species-specific diagnostic PCR, used 454 ultra deep sequencing
to determine whether humans harbored ape parasites at low abundance, and employed
single genome amplification to characterize the genetic diversity of human P. falciparum
in southern Cameroon. Our study is the first to systematically search for Plasmodium
zoonoses in west central Africa, thus providing new insight into the host range of human
and great ape parasites.

2.3 Results
Molecular Characterization of Human Plasmodium Infections in Rural Cameroon
Cameroon is an area of high malaria endemicity, with nearly 100% of clinical cases
believed to be caused by P. falciparum (40). However, few of these infections have been
molecularly characterized and the extent of parasite diversity, both at the intra- and interspecies level, is largely unknown. Studying the epidemiology and natural history of
human immunodeficiency virus type 1 (HIV-1) infections in sub-Saharan Africa, we
previously collected large numbers of buffy coat samples from humans native to rural
Cameroon (45). These samples, which represent thin layers of leukocytes and platelets
on the surface of sedimented erythrocytes, frequently contain Plasmodium DNA, since
parasite infected red blood cells tend to accumulate immediately below the leukocyte
layer (46). All samples were obtained from individuals living in close proximity to the
habitat of Laverania infected apes (Fig. 2-1), thus providing a unique opportunity to
search for zoonotic Plasmodium infections.
To characterize the Plasmodium species that commonly infect humans in rural
12

Cameroon, we first selected 318 buffy coat specimens from inhabitants of seven remote
villages (SI Appendix, Table S1). These study sites were selected because of the high
Laverania prevalence rates in chimpanzee and gorilla populations in adjacent forest
regions (Fig. 2-1A). All sampled individuals lived in close proximity to ape habitats (Fig.
2-1B), and included forest dwellers, hunters, members of local pygmy tribes and
individuals who lived at logging concessions. Given their lifestyles, we reasoned that at
least some of the study subjects were exposed to ape Plasmodium infected Anopheles
mosquitoes. To examine whether such exposures had resulted in parasite transmission,
we screened buffy coat DNA for ape parasites by conventional PCR. Using primers
previously shown to amplify ape Laverania parasites with high sensitivity and specificity
(26), we targeted a 939 bp region (cytb gene) of the Plasmodium mitochondrial (mt)
DNA genome (Fig. 2-2). This analysis identified 194 of the 318 blood samples to be PCR
positive (61%), all of which contained human parasites as determined by direct
sequencing: 181 samples contained P. falciparum, 12 samples contained P. ovale, and
one sample contained P. malariae as the predominant Plasmodium species (SI
Appendix, Table S1). From this experiment, we concluded that zoonotic Laverania
infections, if they indeed occurred, were rare and unlikely to represent single species
infections.
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Figure 2-1. Screening of humans in rural Cameroon for zoonotic Plasmodium
infections.
(A) Location of human study sites (red stars). Eight rural villages were selected for
molecular epidemiological studies because of their proximity to wild-living chimpanzee
(yellow circles) and gorilla (yellow hexagons) populations known to harbor Plasmodium
infections at high prevalence rates. Previously estimated infection rates (26) are shown
for the most proximal field sites (denoted by a two-letter code). Country borders, major
rivers and the capital city of Yaoundé (red triangle) are also shown. A red star with
asterisk highlights the location of five closely spaced villages (Mboumo, Eboumetoum,
14

Aviation, Nkonzu, and Kompia). (B) View of one rural village, depicting the close
proximity of human residences and sleeping quarters to the surrounding forest
(photograph credit, Bernadette Abela).
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Figure 2-2. Schematic representation of the Plasmodium mitochondrial genome.
DNA fragments amplified for diagnostic purposes (cytb, BsrI, P. vivax), 454 deep
sequencing (454), and single genome amplification (mtDNA-3.3 kb; mtDNA-3.4kb) are
shown in relation to cytochrome b (cytb), cytochrome c oxidase subunit I (coxI) and
cytochrome c oxidase subunit III (coxIII) coding regions, respectively. The positions of
four single nucleotide variants (SNV1-SNV4), which distinguish human P. falciparum
from ape Laverania parasites, are shown in red.
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A Diagnostic PCR Capable of Differentiating Human and Ape Laverania Species
Aligning several hundred ape and human Plasmodium mitochondrial genomes, we had
previously noted four single nucleotide variants (SNVs) that distinguished all known P.
falciparum strains from the six ape Laverania species (26). One of these (SNV4)
comprised a BsrI restriction enzyme site (ACTGGN) that was present in 134 of 135 ape
Laverania sequences, but was absent from all of 859 human Plasmodium sequences in
the database (Fig. 2-2). To determine whether PCR amplification followed by BsrI
cleavage could be used to screen human blood samples for ape Laverania infections,
we designed primers for a ~700 bp DNA fragment that spanned the diagnostic SNV4
site (Figs. 2-2 and 2-3). Testing these primers on fecal samples from Plasmodium
infected apes, we obtained PCR products that were all cleaved by BsrI and yielded the
expected fragments for the respective ape Plasmodium species (Fig. 2-3A and B). In
contrast, amplicons from human P. falciparum, P. malariae and P. vivax reference
strains were not cleaved by BsrI, and although P. ovale amplicons were cleaved once,
the resulting fragments were readily distinguishable from those of the ape parasites (not
shown). BsrI cleavage products were also visible in mixtures of human and ape parasite
DNAs, including in preparations that contained P. falciparum at a 10-fold excess (not
shown). These data indicated that PCR amplification, followed by BsrI cleavage,
represented a viable screening approach for zoonotic Laverania infections, even when
ape and human parasites were present in mixed-species infections.
Using this Plasmodium species–specific PCR assay, we screened 1,165 buffy
coat samples from villagers native to southeastern Cameroon (Fig. 2-1). For control, we
also analyzed 85 samples from HIV-1 infected individuals in the capital city Yaoundé.
Testing a total of 1,250 samples, we amplified BsrI-specific fragments from 872 of them
(SI Appendix, Table S1), three of which were cleaved by BsrI (Fig. 2-3C). Two of these
16

samples (KI051 and EC1592) yielded PCR cleavage products consistent with P. ovale
infection, which was confirmed by sequence analysis. The third sample (EC1041), from
a child in Mboumo, yielded ape-specific PCR cleavage products of 395 bp and 316 bp,
respectively (Fig. 2-3C). However, sequence analysis failed to confirm ape Laverania
infection, identifying instead a P. falciparum variant that exhibited a single point mutation
at the SNV4 site. This was confirmed after sequencing the entire mitochondrial genome
of this variant, which contained the SNV4 point mutation, but lacked additional ape
Plasmodium specific signatures. Thus, the Bsr1 diagnostic PCR had uncovered a rare P.
falciparum variant whose mitochondrial sequence was identical to that of other P.
falciparum strains, except for a single (ape-like) back mutation at the SNV4 site.
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Figure 2-3. A Plasmodium species-specific PCR capable of differentiating human
and ape Laverania parasites.
(A) Predicted BsrI cleavage products for different Plasmodium species infecting humans
and apes. A red vertical line highlights a BsrI site unique to ape Laverania parasites. A
second BsrI site found only in P. adleri, P. blacklocki and P. ovale is highlighted in blue.
(B) Diagnostic PCR of ape Laverania infections. All Laverania positive ape fecal
samples were PCR positive (upper panel) and yielded appropriately sized fragments
upon BsrI cleavage (lower panel). (C) Diagnostic PCR of human Plasmodium infections.
All Plasmodium positive human samples yielded appropriately sized amplicons (upper
panel), with BsrI cleavage products observed for only three (see text for details).
18

Molecular Characterization of Human Plasmodium Infections by 454 Deep
Sequencing
The combined results of the cytb and BsrI PCR screening studies indicated that the vast
majority of humans in remote rural Cameroon harbored P. falciparum, which is known to
reach very high blood titers. We thus reasoned that ape Laverania parasites -- if they
were transmitted to humans -- would likely replicate less efficiently and represent only a
minor fraction of the total parasite burden within an infected individual. To increase the
likelihood of detecting such variants, we developed an ultra-deep sequencing approach,
which is known to generate tens of thousands of sequences of the same genetic locus
and can thus detect low abundance variants with great sensitivity (47-49). Specifically,
we used the 454 GS FLX Titanium chemistry to sequence a 405 bp fragment of the
Plasmodium mtDNA genome that included three of the four diagnostic SNVs (Fig. 2-2)
and could thus be used to differentiate even the closest human and ape parasites (SI
Appendix, Fig. S1).
To explore the utility of the 454 sequencing approach, we initially sequenced the
combined DNA of 77 Plasmodium positive human buffy coat samples, which yielded
465,391 high quality reads (for details see SI Appendix, Supplemental Analysis). Each
read was classified by determining its minimum edit distance to a large set of
Plasmodium reference sequences (see Supplemental Analysis in SI Appendix and Table
S2). This approach identified 458,676 reads (98.56%) to represent P. falciparum, 76
reads (0.02%) to represent P. ovale, and 6,266 reads (1.35%) to represent P. malariae
(SI Appendix, Fig. S2 A-C), which was confirmed by phylogenetic analyses of select
reads (SI Appendix, Fig. S3). A single read was classified as P. praefalciparum;
however, closer inspection of its sequence revealed multiple indels that caused
inactivating frameshift mutations as well as a substitution that was not found in any other
19

P. praefalciparum strain. Moreover, this read differed from the closest P. praefalciparum
reference by 5 mutations (SI Appendix, Fig. S2D), but from the closest P. falciparum
reference by 6 mutations, and contained only 2 of the 3 ape specific SNVs. We thus
concluded that this read was erroneously classified as P. praefalciparum due to PCR
and/or 454 process errors, and that there was no evidence of ape Laverania infection in
any of the 77 Plasmodium infected individuals.

Identification of Plasmodium Multi-Species Infections by 454 Deep Sequencing
To extend the search for zoonotic Laverania infections, we selected an additional 438
samples for 454 sequencing, but improved the methodology. First, we inserted a 12-mer
barcode into the sequencing primer to permit the computational sorting of individual
samples (50). Second, we reversed the sequencing direction to increase the number of
reads that covered at least two diagnostic SNVs (SI Appendix, Fig. S1). Third, we
amplified samples using the lowest possible number of cycles to reduce PCR introduced
errors (SI Appendix, Table S3). Finally, we included cloned fragments (3.4 kb) of the P.
falciparum, P. malariae, and P. ovale mitochondrial genome (Fig. 2-2) as controls, which
allowed us to perform a formal error calculation for each pyrosequencing run (for details
see SI Appendix, Supplemental Analysis). The resulting pyrosequencing reads were
sorted by sample and analyzed.
The identification of rare ape Plasmodium parasites necessitated a method that
could differentiate true sequence changes from 454 sequencing error. We thus used a
maximum likelihood based approach to determine which and how many different
Plasmodium species were present in each barcoded human sample (for details see SI
Appendix, Supplemental Analysis). For each sample, we generated pairwise alignments
of all reads with all Plasmodium reference sequences and then applied a model for 454
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sequencing error (SI Appendix, Table S4) to calculate the probability that a read was
derived from a particular reference. Using this approach, we determined the Plasmodium
species composition in all barcoded human samples. Of 437 samples, 349 contained
only P. falciparum, one contained only P. malariae, and 4 contained only P. ovale
sequences (Table 2-1). A further 61 samples contained both P. falciparum and P.
malariae, 13 samples contained both P. falciparum and P. ovale, and 9 samples
contained all three species (Table 2-1). Importantly, none of the human blood samples
contained any of the six ape Laverania species, including P. praefalciparum. Moreover,
none of the samples contained P. vivax sequences.
To be certain that our inability to find ape Plasmodium zoonoses was not due to
technical limitations, we used the identical 454 methodology to amplify and deep
sequence Plasmodium parasites from fecal samples of infected apes. Analysis of 37,644
filtered reads from two western lowland gorillas (Gorilla gorilla gorilla), three central
chimpanzees (Pan troglodytes troglodytes) and one eastern chimpanzee (Pan
troglodytes schweinfurthii) confirmed the presence of all 6 ape Laverania species as well
as P. vivax-like parasites (SI Appendix, Fig. S4). We also characterized the proportion of
humans who harbored multiple P. falciparum variants (SI Appendix, Supplemental
Analysis). Multiple variant infections were detected in 10% of all subjects, with a
maximum of four variants per person (SI Appendix, Table S5, Fig. S5). Importantly,
minor variants could be identified at levels as low as 0.006% of the total parasite burden,
thus providing direct evidence that our deep sequencing approach was capable of
identifying very low abundance Plasmodium variants.
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Table 2-1 Species composition of human Plasmodium infections in Cameroon as
determined by 454 sequencing

a

Identified Specie (s)

Number of Samples

P. falciparum

349

P. falciparum and P. malariae

61

P. falciparum and P. ovale

13

P. falciparum, P. malariae and P. ovale

9

P. ovale

4

P. malariae

1

Total

437

A breakdown of these Plasmodium species for each individual sample is shown in Figure S5

Genetic Diversity of P. falciparum in Rural Cameroon
Although there are over a hundred near-full-length P. falciparum mitochondrial DNA
sequences in the database, little to nothing is known about the extent of genetic diversity
of this parasite in central Africa. In particular, there are no molecularly characterized
human strains from areas where wild-living apes are endemically infected with Laverania
parasites. To characterize the P. falciparum variants prevalent in rural Cameroon, we
selected Plasmodium-positive samples from seven different locations (SI Appendix,
Table S1) and subjected them to single-genome amplification (SGA) targeting the region
of the mitochondrial genome (3.4 kb) known to exhibit the greatest diversity between ape
and human Laverania lineages (Fig. 2-2). We selected SGA rather than conventional
PCR, since this method eliminates Taq polymerase-induced recombination as well as
nucleotide misincorporations in finished sequences, and thus ensures an accurate
representation of parasite variants as they exist in vivo (26, 51). Sequencing between 1
and 8 SGA amplicons per sample, we generated a total of 684 half-genome mtDNA
sequences. Phylogenetic analyses revealed that these represented 69 unique P.
falciparum haplotypes, 62 of which had not previously been reported. Despite this
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diversity, all variants grouped with previously identified P. falciparum sequences, forming
a single well-supported clade within the radiation of P. praefalciparum from gorilla (Fig.
2-4). This was the case even after inclusion of a P. falciparum variant (EC1041, also see
Fig. 2-3) that contained one of the three ape-specific SNVs at the BsrI cleavage site (Fig.
2-4). These results failed to uncover additional cross-species transmissions, including
human-to-ape transfers, and thus confirmed that extant P. falciparum emerged in
humans following a single introduction of a gorilla parasite.
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Figure 2-4. Phylogeny of P. falciparum strains from rural Cameroon.
Newly derived P. falciparum sequences from humans living in Cameroon (black) are
shown in relation to P. falciparum sequences from GenBank (white) and the Sanger
Institute (grey), as well as to P. praefalciparum and P. reichenowi sequences from
gorillas (green) and chimpanzees (red), respectively. The tree includes 684 new SGAderived 3.4 kb mitochondrial sequences from 229 human samples, including one that
contained a back mutation at the ape specific SNV4 site (highlighted by arrow; also see
Fig. 2-3). Numbers at tips indicate the number of times that a sequence was found in
Cameroon (black), the Sanger dataset (grey) or GenBank (white) (for sequences present
in multiple datasets, numbers are listed in sequence). The tree was inferred using
maximum-likelihood methods (52). Asterisks indicate posterior probabilities above 0.9.
The scale bar represents ten nucleotide (nt) substitutions.

Absence of P. vivax in Humans Native to Southern Cameroon
Although the great majority of individuals in Cameroon are Duffy negative (18), it has
been proposed that P. vivax persists in west central human populations at a very low
frequency (53). Since deep sequencing failed to identify evidence of P. vivax infection in
515 individuals, we considered the possibility that the 454 primers were less efficient in
amplifying P. vivax compared to the other Plasmodium species, and thus designed new
P. vivax specific primers in the mtDNA cox1 gene (Fig. 2-2). Using these to screen 558
Plasmodium positive human samples, we identified 47 that yielded a visible amplification
product (SI Appendix, Table S6). However, none of these represented P. vivax or P.
vivax-like infections as determined by sequence analysis of the corresponding amplicon.
Instead, 37 of the PCR positive samples contained P. malariae, while the remaining 10
contained P. ovale. Moreover, sequence analysis of the Duffy promoter region from 90
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human samples confirmed a Duffy negative phenotype in all of them (SI Appendix, Table
S6). Thus, using both conventional PCR and 454 deep sequencing approaches, we
found no evidence of P. vivax infections in individuals living in rural Cameroon.

2.4 Discussion
Chimpanzees and gorillas harbor at least ten different Plasmodium species, including six
of the subgenus Laverania that are closely related to P. falciparum (25-27, 29, 30). The
discovery of this previously unrecognized reservoir has prompted concerns that wildliving apes might constitute a source of recurrent human infection (25, 32, 44). In this
study, we set out to examine this possibility for several reasons. First, the ape reservoir
is substantial, both in terms of geographic distribution and complexity of Plasmodium
species. Second, both western gorillas (G. gorilla) and common chimpanzees (P.
troglodytes) are infected throughout their habitat, indicating widespread endemicity
throughout west central and central Africa. Third, Plasmodium zoonoses can have
significant public health impact. A case in point is P. knowlesi, a macaque parasite that
has shown to cause hundreds of cases of human malaria every year (4, 5). Finally,
Plasmodium zoonoses have been misdiagnosed in the past: P. knowlesi was initially
mistaken for P. malariae, ultimately requiring the development of molecular tools to
facilitate its detection (5). Given that malaria infections in central Africa are rarely
genetically (or even morphologically) characterized, we considered the possibility that
ape Plasmodium zoonoses might have also been overlooked. To test this, we developed
diagnostic PCR assays and next generation sequencing approaches that permitted the
detection of rare Plasmodium variants, even when they occurred in the context of mixedspecies infection with P. falciparum. Using these approaches to test 1,400 blood
samples from individuals native to rural Cameroon, we failed to detect previously
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unknown human Plasmodium infections (SI Appendix, Table S1). There was no
evidence for zoonotic infection with any of the six ape-specific Laverania species or nonLaverania parasites identified only in wild apes (26). Instead, we detected P. falciparum,
P. ovale and P. malariae in a large fraction of individuals, both as mono- and mixed
species infections (Table 2-1; SI Appendix, Fig. S5). From these data, we conclude that
ape Laverania zoonoses can be ruled out as an ongoing threat to public health in west
central Africa.
Although we failed to find ape Laverania infections in humans, our data cannot
exclude the possibility of very rare transmission events. Such events would require the
screening of a much larger number of individuals from multiple forest environments. In
this context, it is important to note that the Anopheles species that transmit Laverania
parasites among wild apes have yet to be identified. It is conceivable that the ecology,
distribution and feeding preferences of these vectors play a much greater role in
determining the likelihood of zoonotic transmission than the mere geographic proximity
of human habitations to infected ape populations. Nonetheless, it seems unlikely that the
absence of ape Laverania infection in rural communities is solely due to a lack of human
exposure. This is because even among endemically infected chimpanzees and gorillas,
there is no evidence that Laverania parasites cross between the two ape species (26).
This remarkable host specificity suggests a restriction at the parasite-host interface,
which is supported by comparisons of P. falciparum and P. reichenowi gene sequences.
It is known that the genes involved in erythrocyte invasion are evolving rapidly between
Laverania parasites (54). Moreover, erythrocyte invasion of P. falciparum is absolutely
dependent on the interaction of its PfRh5 ligand with the human Ok blood group antigen
basigin (55). Human, chimpanzee and gorilla homologues of basigin are highly
divergent, suggesting that ape Laverania species have to overcome significant adaptive
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hurdles before they can spread efficiently in a different host.
Given these restrictions, the question arises how the gorilla precursor of P.
falciparum managed to colonize humans. One possibility is that P. praefalciparum
underwent a very specific mutation in a host-compatibility factor that changed its host
preference from gorilla to human. Since P. falciparum emerged only once (Fig. 2-4), this
mutation must have been difficult to generate and/or must have arisen under
exceedingly favorable transmission conditions. Another possibility is that the immediate
precursor of P. falciparum was the product of a rare recombination event. Regardless of
the circumstances, it seems clear that the generation of an ape Laverania strain that is
capable of spreading in humans is an extremely rare event, which may explain why we
failed to detect such variants.
In addition to Laverania species, wild-living chimpanzees and gorillas also harbor
P. vivax, P. malariae, and P. ovale-like infections. Since very few of these ape parasites
have been molecularly characterized, it remains unknown whether they represent
members of the same or different Plasmodium species as their human counterparts.
Transmission studies conducted nearly a hundred years ago demonstrated that nonLaverania species cross between apes and humans more readily than Laverania
species (56-60). Two species, P. schwetzi and P. rodhaini have been experimentally
transmitted to humans in the past (57, 58, 61). As neither species has been molecularly
characterized, it is unknown whether they represent the P. vivax, P. malariae and/or P.
ovale-like infections that have more recently been identified in wild apes. It will thus be
important to characterize more of these ape parasites to understand their evolutionary
history and characterize their zoonotic potential.
The genetic diversity of P. falciparum in central Africa is largely unknown since
only very few strains from this geographic region have been molecularly characterized. It
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has thus been argued that this lack of sequence information has confounded previous
evolutionary analyses and lead to erroneous conclusions concerning the origin of P.
falciparum (62). In particular, it has been proposed that P. praefalciparum is more likely
the result of a human-to-gorilla transmissions of P. falciparum than the other way around
(62). To examine this possibility, we amplified mitochondrial half genome sequences
from 229 P. falciparum positive samples collected in remote rural areas of Cameroon.
We found that P. falciparum strains from rural Cameroon were indeed genetically more
diverse than previously appreciated. Analyzing 684 single template-derived sequences,
we identified 69 unique P. falciparum variants, 62 of which had not previously been
reported. However, none of these variants changed previous conclusions concerning the
evolutionary history of P. falciparum. Phylogenetic analysis revealed that all newly
characterized variants grouped with previously reported P. falciparum strains, forming a
well-supported clade within the P. praefalciparum radiation (Fig. 2-4). An additional 354
sequences of cosmopolitan P. falciparum strains from the Sanger Institute supported this
conclusion (35), indicating that all human P. falciparum sequences coalesced to a single
common ancestor. Thus, the addition of over 1,000 new P. falciparum sequences,
including over 600 from individuals living near wild ape populations, confirmed that P.
falciparum is of gorilla origin and emerged in humans following a single cross-species
transmission event (26).
P. vivax is extremely rare in humans in west and central Africa due to the near
fixation of the Duffy-negative phenotype which confers resistance to this parasite (18).
However, a recent study reported P. vivax specific antibodies in 13% of humans living in
Pointe-Noire, a city in the Republic of Congo, suggesting that P. vivax is maintained in a
small fraction of Duffy positive individuals (63). To examine this possibility for rural
Cameroon, we screened nearly 700 human blood samples for P. vivax mitochondrial
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sequences. Using both PCR and 454 sequencing approaches, we failed to identify P.
vivax infection in inhabitants from 7 different rural villages. Finally, all human samples
tested were Duffy negative, suggesting that the fraction of Duffy positive individuals in
rural areas of west central Africa is exceedingly low. These data differ from results of
others who have reported the presence of P. vivax in Equatorial Guinea and Angola. In
these studies, the P. vivax infected individuals were either Duffy positive (64) or
diagnosed solely based on P. vivax specific PCR products without sequence verification
(65). Given the frequency of off-target amplification even with P. vivax specific primers,
any P. vivax diagnosis in central Africa should be confirmed by sequence analysis. Until
this is done, the presence of P. vivax in rural west central Africa remains questionable.

2.5 Methods
Sample Collections
Human buffy coat samples (n=1,403) were selected from anonymized sample collections
previously obtained for molecular epidemiological studies of HIV-1 in Cameroon(45).
Fecal samples from wild-living apes known to contain Laverania and non-Laverania
parasites served as positive controls (26).

Plasmodium Species Specific PCR
Human buffy coat samples were first screened for Plasmodium cytb sequences by
conventional PCR as described (26). Positive samples were further characterized using
a Plasmodium species specific PCR and BsrI digest approach (See SI Appendix,
Supplemental Methods for more details).
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Pyrosequencing
A 405 bp fragment of the mitochondrial genome that spanned three SNVs unique to ape
Laverania parasites (Fig. 2-2) was amplified and sequenced on a Genome Sequencer
FLX Titanium Series (Roche) (See SI Appendix, Supplemental Methods for more
details).

Single Genome Amplification and Sequencing
To derive Plasmodium mitochondrial sequences without PCR induced substitutions
and/or recombination, a 3.4 kb fragment of the Plasmodium mitochondrial genome was
amplified and sequenced directly from a subset of cytb PCR positive samples (n = 229)
as previously described (26).

Phylogenetic Analyses
SGA derived 3.4 kb mitochondrial sequences were aligned with human and simian
reference sequences. Trees were inferred using Maximum-Likelihood and Bayesian
methods (See SI Appendix, Supplemental Methods for more details).

P. vivax specific PCR
Human samples were screened for P. vivax infections by nested PCR as described (66).
Nested primers were specifically designed to avoid off-target amplification of P.
falciparum or other Laverania species, and were shown to amplify ape P. vivax-like
parasites as well as human P. vivax with high sensitivity and specificity (66) (see SI
Appendix for primer sequences and amplification conditions).
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Duffy Phenotype
Buffy coat DNA was extracted and used to amplify the Duffy promoter region by nested
PCR. The Duffy phenotype was determined by direct sequencing (See SI Appendix,
Supplemental Methods for more details).

GenBank Accession Numbers
All newly derived SGA sequences are available under GenBank accession numbers
KC175306-KC175322 and KC203521-KC203587. The 454 pyrosequencing read data
have been deposited in the National Center for Biotechnology Information Sequence
Read Archive (SRA) under accession number SRP019191.
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3.1 Abstract
African apes harbor six Plasmodium species of the subgenus Laverania, one of which
gave rise to human P. falciparum (26). Here, we used a novel phi29 polymerase-based
selective amplification strategy (39) to sequence the genomes of three chimpanzee
parasites, including one that is closely (P. reichenowi) and two that are distantly (P.
gaboni) related to P. falciparum. Analysis of these sequences demonstrated a nearidentical core genome (>4,600 orthologs), but also a 10-fold higher within-species
diversity among the chimpanzee parasites, revealing a very recent origin of P.
falciparum in humans. Surprisingly, genome-wide analyses uncovered a striking
expansion and diversification of a multi-gene family (67) involved in erythrocyte
remodeling, and showed that a region on chromosome 4, which encodes the essential
invasion genes RH5 and CyRPA, was horizontally transferred into a recent P. falciparum
ancestor. These results provide a new paradigm for characterizing cryptic pathogen
species (68) and reveal evolutionary events that likely predisposed the precursor of P.
falciparum to successfully colonize humans.
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3.2 Introduction
Plasmodium falciparum, the cause of malignant malaria in humans, evolved following a
single cross-species transmission event involving a parasite that naturally infects
western gorillas (Gorilla gorilla)( 26). To elucidate key events that led to its emergence,
we characterized the evolutionary history of related ape Laverania parasites. All
Plasmodium reference genomes generated to date are derived from purified parasites
grown to high titers in red blood cells (RBCs) in vitro or susceptible host species in vivo
(9, 69-73). Since blood samples from endangered chimpanzees and gorillas are not
readily available, efforts to culture ape Laverania parasites, which are highly species
specific (26), have remained unsuccessful. To date, only a single genome of the
chimpanzee parasite P. reichenowi has been sequenced, following extensive in vivo
passage and amplification in experimentally infected, splenectomized chimpanzees (69,
74). Since this method of parasite enrichment is neither ethical nor practical, we
developed a strategy to selectively amplify and sequence near full-length Plasmodium
genomes from subpatently-infected ape blood.

3.3 Results
Traditional whole genome amplification methods utilize the highly-processive phi29
polymerase and random primers to generate DNA fragments of up to 70kb in length, but
amplify all templates within a sample with near-uniformity (75-78). Since microbial and
host genomes differ in the frequency of common sequence motifs (79), we reasoned that
it should be possible to design primers that would amplify pathogens selectively, even if
they represented only a small fraction of the sample DNA. Testing this concept on
Wolbachia infected fruit flies, we found that selective whole genome amplification
(SWGA) generated sufficient quantities of bacterial genomes for next generation
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sequencing (39). To extend this method to more complex eukaryotic pathogens, we
tested whether SWGA could amplify the multi-chromosomal genomes of Plasmodium
parasites from unprocessed human and ape blood samples. Searching for short (8-12
bp) sequences that are overrepresented in P. falciparum and P. reichenowi, but
underrepresented in the genomes of their primate hosts (Online Methods), we identified
2,418 motifs that occur frequently in the parasite DNA (i.e., spaced on average less than
50,000 bp apart), but only rarely (i.e., spaced on average more than 500,000 bp apart) in
human and chimpanzee DNA (Figs. 3-1A and B). We selected two sets of SWGA
primers (Supplementary Fig. 3-1) based on their distribution across the parasite
genomes and their DNA binding properties, and tested them on human DNA containing
known quantities (0.001% to 5%) of P. falciparum DNA (Online Methods). These
experiments showed that SWGA amplified P. falciparum genomes with remarkable
breadth and selectivity over a wide range of concentrations, especially when results from
independent amplifications were combined (Fig. 3-1C). Of ~2.5 million MiSeq reads
derived from human DNA containing as little as 0.001% P. falciparum DNA (19 genome
equivalents), ~1.7 million (70%) mapped to the P. falciparum genome, indicating a
70,000-fold enrichment of the parasite compared to the host DNA (Table 3-1). Read
coverage was even across all 14 chromosomes, except for the sub-telomeres where low
complexity sequence precludes accurate mapping (Supplementary Fig. 2). Stochastic
amplification was seen only at the lowest (0.001%) parasite dilution (Supplementary Fig.
2). Thus, SWGA generated high-quality Plasmodium core genomes from samples
containing large quantities of contaminating host DNA.
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Table 3-1 Selective whole-genome amplification of P. falciparum from mixtures of
human and parasite DNA.
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b
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a
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1
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1
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Average distance between sequence motifs
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c
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Figure 3-1. Selective whole genome amplification (SWGA) of Plasmodium
parasites.
(A,B) Selection of SWGA primer sets. (A) The average distance (kb) between the
10,000 most frequent parasite motifs (color coded by length) is plotted for both the P.
falciparum (Pf3D7) and human (GRCh37) genomes. The red box highlights motifs that
are spaced (on average) less than 50,000 bp apart in the P. falciparum, but more than
500,000 bp apart in the human genome. (B) Average distances between the sequence
motifs shown in a, but plotted for the P. reichenowi (PrCDC) and chimpanzee
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(Pan_troglodytes-2.1.4) genomes. Red dots indicate all motifs that fall within the red box
in a, with circles and stars denoting those selected for SWGA primer sets 6A and 8A,
respectively (Supplementary Fig. 1). (C) Validation of the SWGA primer sets identified in
A and B. Human genomic DNA containing known quantities of P. falciparum (5% to
0.001%) were subjected to consecutive rounds of SWGA, using primer set 6A in the first
and primer set 8A in the second round, respectively. The number of total base pairs (in
millions) sequenced is shown in relation to the percent coverage of the P. falciparum
(Pf3D7) genome for five parasite concentrations. DNA mixtures were subjected to two
independent amplifications, with individual and combined results shown in blue and red,
respectively (the expected genome coverage without SWGA is shown in green).

We next used SWGA to amplify the genomes of three chimpanzee parasites,
representing both close (P. reichenowi) and very distant (P. gaboni) relatives of P.
falciparum (26). Whole blood samples were obtained from sanctuary chimpanzees (Pan
troglodytes) during their annual health examination and tested for Plasmodium infection
using conventional PCR. Parasite DNA positive blood samples were further
characterized by limiting dilution (single template) PCR amplification of eight
mitochondrial, apicoplast, and nuclear loci to determine their Plasmodium species
composition (26, 80). This analysis identified one sample (SY57) to contain almost
exclusively (>99%) P. reichenowi and two others (SY75 and SY37) to contain only P.
gaboni DNA (Supplementary Table 1). In each case, the parasites comprised only a
miniscule fraction of the total blood DNA (0.0054%, 0.14% and 0.00081% for SY57,
SY75 and SY37, respectively). To reduce the contaminating host DNA, we digested all
samples with methylation dependent restriction enzymes (MspJI and FspEI) known to
cleave ape, but not Plasmodium, genomic DNA (38), and then used the digestion
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products for SWGA and Illumina sequencing (Online Methods). This approach yielded
27, 31 and 39 million MiSeq reads for samples SY57, SY75 and SY37, respectively, of
which 89%, 73% and 61% mapped to Plasmodium sequences (Supplementary Table 1).
Sequence coverage was even across all 14 chromosomes, with no evidence for
selective sequence loss, including near the ends of some chromosomes (Supplementary
Fig. 3). Reads from sample SY57 were mapped to the P. reichenowi PrCDC reference
and shown to cover 96% of its genome (at a coverage depth of 5-fold or higher read).
Since there is no published P. gaboni genome, reads from samples SY75 and SY37
were mapped to the P. falciparum Pf3D7 reference and shown to cover 79% and 69% of
its genome (at ≥5x), respectively (Supplementary Table 1). This lower coverage was not
due to a reduction in selective amplification, but the difficulty of mapping reads to a
highly divergent reference sequence.
Using reference guided iterative assembly (Online Methods) (81), we generated
draft genomes for PrSY57 and PgSY75, which contained 18.5 Mb and 18.9 Mb of
chromosomal, as well as 1.4 and 0.8 Mb of sequence that could not be placed within the
core genome, respectively (Table 3-2). Due to the very small quantities of parasite DNA,
sequence coverage for PgSY37 was lower, yielding 15 Mb of chromosomal and 8 Mb of
unplaced sequences. Syntenic annotation transfer and ab initio gene prediction identified
4,920, 4,962 and 4,179 full-length and partial protein coding genes in PrSY57, PgSY75
and PgSY37, respectively, which included 98.3%, 98.7% and 85.7% of the core genes in
the respective reference sequences (Table 3-2). In genomic regions that were syntenic
among all three species, there were only 5 P. gaboni genes that were missing in P.
falciparum and/or P. reichenowi, and only 5 P. reichenowi and/or P. falciparum genes
that were absent from P. gaboni (Supplementary Table 2, Supplementary Fig. 4). Of 76
pseudogenes identified in the three Laverania species, only 7, 14 and 9 were specific for
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P. falciparum, P. reichenowi and P. gaboni, respectively (Supplementary Table 3). Thus,
the core genome of ape and human Laverania parasites is highly conserved even
among the most divergent species within the subgenus.
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Table 3-2 Genome features of P. gaboni and P. reichenowi
P. reichenowi

P. gaboni

P. gaboni

PrSY57

PgSY75

PgSY37

18,853,635

18,465,530

15,330,638

1,012

331

n/a

784,231

1,442,089

8,902,276

Unplaced contigs

741

809

14,793

Chromosomes

14

14

14

18.6

18.3

17.1

4670 (98.3%)

4689 (98.7%)

4071 (85.7%)

4359 (91.8%)

4382 (92.2%)

3295 (69.4%)

311 (6.5%)

307 (6.5%)

776 (16.3%)

235 (23.8%)

222 (33.2%)

108 (16.2%)

182 (18.5%)

189 (28.3%)

72 (10.8%)

53 (5.4%)
15

33 (4.9%)
51

36 (5.4%)
0

14
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n/a

tRNA genes

1
42 (93.3%)

7
43 (95.6%)

n/a
32 (71.1%)

rRNA genes

8 (47.1%)

11 (43.3%)

2 (7.7%)

d

4 (23.5%)

10 (38.5%)

2 (7.7%)

Genome ID
Chromosomal assembly (bp)
Chromosomal contigs
Unplaced assembly (bp)

b

GC content (%)
Core protein-coding genes
Full-length

c

d

e

Partial
Subtelomeric protein-coding
c
genes
d
Full-length
Partial

e

Other protein-coding genes
Full-length
Partial

Full-length
Partial

d

e

e

f

a

g

4 (23.5%)

1 (3.8%)

0

71 (75.5%)

67 (65.7%)

49 (48.0%)

66 (70.2%)

61 (59.8%)

40 (39.2%)

5 (5.3%)

6 (5.9%)

9 (8.8%)

45 (76.3%)

58 (85.3%)

n/a

27 (90.0%)

30 (100%)

n/a

2 (6.7%)

0

n/a

tRNA genes

16 (59.3%)

26 (76.5%)

n/a

rRNA genes

0

2 (50%)

n/a

ncRNA genes
Full-length
Partial

d

e

Apicoplast genes
Full-length
Partial

d

e

a

Length of all contigs that could be placed in chromosomes, excluding gaps; bp, base pairs.
b
Length of all contigs that could not be placed in chromosomes (‘bin’), excluding gaps; bp, base pairs.
c
Gene counts excluding splice variants, but including pseudogenes and partial genes; parentheses indicate the
percentage of genes covered in the Plasmodium references Pf3D7 (PgSY75 and PgSY37) and PrCDC1 (PrSY57).
d
Number includes all genes that comprise ≥90% of the lengths of their Pf3D7 or PrCDC orthologs/homologs as well as
all genes that comprise ≥80% of the lengths of their Pf3D7 or PrCDC orthologs/homologs and contain no assembly
gaps.
e
All annotated coding sequences for which homologs could be identified by BLAST search, but did not contain a
sufficiently long sequence to be considered full-length.
f
Genes for which an ortholog could not be unambiguously identified in the reference genome.
g
n/a, not available; the PgSY37 genome was generated by iteratively replacing the PgSY75 genome with PgSY37
reads and replacing the regions that lacked 5-fold coverage with Ns; reads not mapped to PgSY75 chromosomes were
assembled de novo to generate 'unplaced contigs'.
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Availability of new P. reichenowi and P. gaboni genomes allowed us to examine
the within-species diversity among chimpanzee parasites. For comparison, the intraspecies diversity of P. falciparum was calculated using published SNP data from 12
geographically diverse field isolates (see the ‘Methods’ section for details). Comparing
more than 3,000 genes, we found that the two P. gaboni genomes (PgSY75 and
PgSY37) differed at 0.4% of all coding sites, and 1.1% of fourfold degenerate (silent)
sites. Similarly, the two P. reichenowi genomes (PrSY57 and PrCDC) differed at 0.3% of
all coding sites, and 0.9% of fourfold degenerate sites (Table 3-3). Note that, for every
gene, the divergence between the two P. gaboni sequences, or between the two P.
reichenowi sequences, was lower than between these two species, consistent with the
premise that P. gaboni and P. reichenowi are genetically isolated.
In contrast, 12 field isolates of P. falciparum selected from countries around the
world differed on average at only 0.04% of all coding sites, and 0.08% of fourfold
degenerate sites (Table 3-3). To ensure that the higher diversity among the ape
parasites was not an artefact of the SWGA method, we amplified several nuclear loci
that exhibited particularly high sequence diversity (three from P. gaboni and four from P.
reichenowi) using limiting dilution PCR (Supplementary Table 4). The resulting
sequences were identical to the SWGA-derived genomes except for two indels in
difficult-to-assemble regions, which had been excluded from the diversity calculations,
thus further validating the accuracy of the SWGA method (Supplementary Fig. 5). The
distributions of diversity levels across genes were very similar in P. reichenowi and P.
gaboni (Fig. 3-2). This was also the case when the within-species diversity for P.
reichenowi or P. gaboni was compared with the maximum pairwise divergence obtained
for each gene among the 12 P. falciparum field isolates (Supplementary Fig. 6). In all
comparisons, the difference between ape and human parasites reflected significantly
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higher diversity levels in genes distributed across the entire core genome (Sign test,
Pr>Pf and Pg>Pf: p < 2.2e-16). Thus, for both chimpanzee parasite species, including
two P. gaboni strains from the same location, the genetic diversity is about ten times
higher than that seen among P. falciparum strains from different geographic regions
across the globe. This reduced diversity in P. falciparum is consistent with a severe
population bottleneck, which most likely occurred at the cross-species transmission from
gorilla to human.
Table 3-3 Genome features of P. gaboni and P. reichenowi.
Speciesa
Nb
πc
π4d
Genes
πc

π4d

Genes

P. falciparum

12

0.00049

0.00081

4,818

0.00043

0.00079

3,111

P. reichenowi
P. gaboni

2
2

0.00364
0.00407

0.00899
0.01069

4,439
3,331

0.00324
0.00381

0.00876
0.01049

3,111
3,111

a

Values represent weighted mean values across genes. Values at the right are for 3,111 genes available for
all three species.
b
N, number of strains.
c
π, pairwise nucleotide diversity across all non-masked sites;
d
π4, pairwise nucleotide diversity across non-masked 4-fold degenerate sites.
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Figure 3-2. Sequence diversity within three Laverania species and P. vivax.
The average pairwise nucleotide sequence diversity is shown for 3,111 syntenic core
genes at four-fold degenerate sites for 12 geographically diverse strains of P. falciparum
(black), two strains of P. reichenowi (red), and two strains of P. gaboni (blue),
respectively. The average pairwise diversity for 2,753 genes from five strains of P. vivax
is included as a comparator. For P. falciparum strains other than 3D7, diversity
information was obtained from SNP data (only datasets representing single parasite
strains were used for analysis; see Online Methods for more detail). For P. vivax,
diversity information was obtained from previously published SNP data (Neafsey et al.,
2012)

It has long been suspected that P. falciparum has unusually low genetic diversity
(82), although the underlying causes have been the subject of much debate (83).
Genome-wide analysis of human and chimpanzee parasites now show that this low
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diversity is not a general characteristic of Laverania parasites, and therefore not a
consequence of their life cycle (84, 85) nor an artifact of their very A+T-rich genomes.
The expected neutral nucleotide diversity is dependent on the effective population size,
which for a parasite is generally dependent on the population size of its host. While the
effective population size of chimpanzees is higher (2-3x) than that of humans, numbers
of chimpanzees seem unlikely to have been ten times larger than those of humans in the
past (86). A simple explanation for the low diversity in P. falciparum is a very recent
population bottleneck, reflecting the cross-species transmission of its gorilla precursor
(26).
To gain insight into the host specificity of Laverania parasites, we examined
members of multigene families known to function at the host-parasite interface. Many of
these, including members of the var, rif and stevor families, could not be completely
assembled because of their extreme variability and subtelomeric location, although varlike genes have been shown to be present in all ape Laverania species (80). One family
of putative protein kinases, termed FIKK (after a conserved Phe-Ile-Lys-Lys motif in their
amino acid sequence), was of particular interest because it expanded from a single gene
present in all Plasmodium parasites to 20 genes in both P. falciparum and P. reichenowi
(67, 69). Remarkably, the new P. gaboni genome contained 21 FIKK genes, 20 of which
represented clear syntenic orthologs of corresponding P. falciparum and P. reichenowi
genes as demonstrated by phylogenetic analysis (Fig. 3-3A) and chromosomal location
(Supplementary Table 5). The remaining P. gaboni gene on chromosome 9, termed
FIKK9.15,

did

not

have

an

ortholog

in

P.

falciparum

and

P.

reichenowi

(Supplementary Fig. 7A), but was identified in the closest relative of P. gaboni, the gorilla
parasite P. adleri (Supplementary Fig. 7B). These data indicate that the FIKK gene
family underwent an unprecedented burst of gene duplications and rapid diversification
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very early in Laverania evolution, followed by a period of greatly reduced divergence
rates and near stasis of FIKK gene copy numbers after the radiation of extant Laverania
species (Fig. 3-3A). Although their exact function remains to be determined, the P.
falciparum FIKK genes are expressed at different time points during the erythrocytic
cycle (87) (Fig. 3-3B), with all but the ancestral FIKK8 believed to be exported into the
host erythrocyte to contribute to the remodeling of its cytoskeleton and surface
membrane structures (67, 88-90). The slow rate of evolution of FIKK8 (Fig. 3-3A)
suggests that it retained its original, cytosolic function consistent with similar expression
profiles of its ortholog in P. vivax (87, 91). However, all other family members appear to
have acquired novel, non-redundant and seemingly essential functions, since only very
few have become pseudogenes in one or more Laverania species. For example,
FIKK7.2 and FIKK14 are pseudogenes in P. falciparum (Fig. 3-3A), but lack the
respective inactivating mutations in P. praefalciparum and P. adleri (Supplementary Fig.
8). Similarly, FIKK9.5 is a pseudogene in P. gaboni and P. reichenowi, but is intact in P.
falciparum (Fig. 3-3A) and possibly other Laverania species. Interestingly, other
exported multigene families that have undergone lineage specific expansion in P.
falciparum and P. reichenowi (92), including DNAJ and PHISTb genes, also have
syntenic orthologs in P. gaboni (Supplementary Table 7). Thus, it seems likely that the
rapid multiplication of the FIKK gene family, perhaps in concert with other members of
the Plasmodium exportome (proteins exported from the parasite) (92), is at least partly
responsible for the unique biology of Laverania parasites, including their ability to
mediate red blood cell cytoadhesion, tissue sequestration and/or host immune escape
(93, 94).
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Figure 3-3. Expansion and diversification of the FIKK multigene family in the
Laverania subgenus.
(A) Phylogeny of FIKK genes from P. falciparum (green), P. reichenowi (red), P. gaboni
(blue), and non-Laverania species (black). FIKK genes are labeled according to their P.
falciparum orthologs, with the new P. gaboni gene designated FIKK9.15. Open symbols
indicate pseudogenes in all members of the species (FIKK7.2 is intact in some strains of
P. falciparum). The tree was inferred using maximum-likelihood methods(52) using an
alignment of first and second codon positions. Internal branches with bootstrap support
of less than 70% are collapsed. The scale bar represents 0.05 substitutions per site. (B)
Expression profiles of P. falciparum FIKK genes. Previously published microarray data
(87) from 21 clonal P. falciparum strains were used to calculate the expression levels of
19 FIKK genes at different time points during the intra-erythrocytic lifecycle (data for the
remaining FIKK gene were not available). Colors represent mRNA expression levels
relative to a reference pool, with red, black and green indicating higher, equal, and lower
expression levels than the reference pool, respectively. Genes were arranged to
illustrate the sequential nature of FIKK gene expression.
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To investigate whether any genes exhibit unusual patterns of divergence among
P. falciparum, P. reichenowi and P. gaboni, we calculated inter-species distances for
4,500 syntenic orthologs (Supplementary Data). As expected from mitochondrial DNA,
the pairwise distance between P. falciparum and P. reichenowi was about four-fold lower
than the distance of either species to P. gaboni. However, there were four genes for
which these relationships were reversed, that is the P. falciparum/P. reichenowi distance
was about four-fold higher than the P. falciparum/P. gaboni distance (Supplementary
Data). Remarkably, these four genes are all located on the same 8 kb segment of
chromosome 4 (Fig. 3-4A) and include two essential invasion genes encoding the
reticulocyte binding-like homologous protein 5 (RH5) and the cysteine-rich protective
antigen (CyRPA) (55, 95). To investigate this further, we amplified regions from both
within and outside the 8 kb segment from additional ape Laverania species
(Supplementary Table 8, Supplementary Fig. 9). Whereas a phylogeny derived from the
EBA165 gene (outside the 8 kb segment) was consistent with previous topologies (26),
we found an unexpectedly close relationship of the P. falciparum/P. praefalciparum
clade with the gorilla parasite P. adleri in trees based on the RH5 and CyRPA genes
(Fig. 3-4B; Supplementary Fig. 9). Mating between members of different Laverania
species is unlikely to generate viable progeny, and so the discordant evolutionary history
of this 8 kb region is most likely the result of horizontal gene transfer (HGT) from an
ancestor of P. adleri to an ancestor of P. praefalciparum. Cultured erythrocyte-stage
parasites of P. falciparum take up DNA spontaneously from their host cell cytoplasm (96)
and infected red blood cells have been shown to communicate via exosome-like vesicles
that are capable of delivering genes (97). Thus, this HGT most likely occurred during the
blood stage infection of a gorilla harboring multiple Laverania species (26).
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Figure 3-4. Horizontal gene transfer between two Laverania species includes two
essential invasion genes.
(A) Identification of an 8 kb transferred segment on chromosome 4. Interspecies
distances (color coded) are shown for syntenic orthologs of P. falciparum, P. reichenowi
and P. gaboni. Four genes, including the essential invasion genes CyRPA and RH5,
exhibit an unusually high P. falciparum/P. reichenowi (yellow) and an unusually low
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P. falciparum/P. gaboni

(aqua)

distance,

respectively.

Genes

are

ordered

by

chromosomal location. Since RH4 is absent from P. gaboni (see Supplementary Fig. 4),
only the P. falciparum/P. reichenowi distance is shown. (B,C) Phylogenetic relationships
of Laverania RH5 and EBA165 gene sequences, revealing an unexpectedly close
relationship between the P. praefalciparum/P. falciparum and P. adleri lineages in RH5.
Laverania parasites are colored coded according to their host species (chimpanzee, red;
gorilla, green; human, black). Trees were inferred by maximum likelihood methods (52).
Numbers at internal nodes represent bootstrap support values (98) (only numbers >80%
are shown). The scale bars represent 0.02 substitutions per site (additional phylogenies
are shown Supplementary Fig. 9).

Recent studies have shown that RH5, CyRPA and the RH5-interacting protein
(RIPR) form a multiprotein complex that is attached to the merozoite surface via the
CyRPA glycosylphosphatidylinositol (GPI) anchor (95). This adhesion complex ensures
the proper positioning of RH5, which lacks a transmembrane domain, thus facilitating its
binding to the erythrocyte receptor basigin, an obligate step in the erythrocyte invasion
process (99). Given the essential nature of these interactions, the acquisition of
“matching” RH5 and CyRPA coding regions on both ends of a mosaic fragment seems
unlikely to represent a chance event (Fig. 3-4A). Indeed, the initially transferred fragment
may have been longer, but would have been reduced in size by successive
recombination events eroding its edges until any further shortening was deleterious
because it failed to conserve compatible RH5 and CyRPA proteins. Breakpoint analysis
of the fragment boundaries provides support for this hypothesis (Supplementary Fig. 10).
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3.4 Discussion
Although the origin of P. falciparum is now well established, nothing is known about the
evolutionary and mechanistic processes that led to its emergence. Studying Plasmodium
infections of great apes is challenging because of their endangered status, which
precludes interventions that could cause or risk harm. Here, we describe a new
approach that generates high quality Plasmodium genome sequences from samples that
contain large amounts of contaminating host DNA. This provides an opportunity to
characterize additional Laverania species, in particular the gorilla precursor of P.
falciparum, by selectively amplifying parasite genomes from small quantities of
unprocessed blood or even infected mosquito DNA (100, 101). While the adaptive
pathways required for the colonization of humans remain to be elucidated, it is tempting
to speculate that the horizontal gene transfer of RH5, which represents a major P.
falciparum host specificity determinant (102), conferred a fitness advantage that may
have predisposed P. praefalciparum to infect humans. However, even if this was the
case, HGT alone was clearly not sufficient since all characterized strains of P.
praefalciparum carry this locus, yet there is evidence for only a single cross-species
transmission event (26, 32, 103). Moreover, the HGT likely occurred long before the
emergence of P. falciparum (Fig. 3-4B). Previous attempts to date the last common
ancestor of P. falciparum have yielded estimates of up to several hundred thousand
years ago (29, 104), but all of these made assumptions concerning the Plasmodium
molecular clock that can not be substantiated. In contrast, other data, including the
timescale of the spread of P. falciparum resistance mutations in African populations
(105), the evolutionary history of its main mosquito vector Anopheles gambiae (106),
and the low probability of maintaining endemic P. falciparum infections in human huntergatherer populations (107, 108) support a much more recent emergence or expansion of
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P. falciparum, within the last 10,000 years. Our findings of a 10-fold lower within-species
diversity in P. falciparum compared to P. gaboni and P. reichenowi is consistent with the
latter estimate. Thus, the event(s) that promoted the emergence of P. falciparum in
humans may have been associated with the transition from a hunter-gatherer to a more
settled lifestyle, possibly involving a change in mosquito host preference, such as the
ability to efficiently infect the main human vector A. gambiae (109).

3.5 Methods
Ape samples.
Blood samples (5-10 ml) were collected from sanctuary chimpanzees (Pan troglodytes)
living in outside enclosures in close proximity to wild apes at the Sanaga Yong
Chimpanzee Rescue Center (SY) in Cameroon (n=26) and the Tchimpounga
Chimpanzee Rehabilitation Center (TC) (n=1) in the Republic of the Congo. Members of
both the central (P. t. troglodytes) and the Nigeria-Cameroonian (P. t. ellioti) subspecies
were sampled. Blood was obtained for veterinary purposes only or represented leftover
specimens from yearly health examinations. None of the chimpanzee exhibited
symptoms of malaria at the time of sampling. Most blood samples were preserved in
RNAlater (1:1 vol/vol) without further processing, except for 8 samples, which were
subjected to density gradient centrifugation in the field to enrich for red blood cells (RBC)
(Supplementary Table 6). Briefly, blood was diluted in PBS (1:1 vol/vol), layered over
Lymphoprep (Axis-Shield), and then centrifuged at 800xg for 20 minutes. After removal
of the mononuclear cell layer, the purified erythrocytes were preserved in RNAlater (1:1
vol/vol). All samples were transported at ambient temperature and subsequently stored
at -80 °C. Small quantities of blood were also obtained from two western gorillas (Gorilla
gorilla) of unknown geographic origin (SA), who were killed by hunters and confiscated
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by the anti-poaching program of the Cameroonian Ministry of Environment and Forestry.
Blood was collected from around the inflicted wounds and frozen directly without
preservation. Ape fecal samples (n=55) were selected from an existing bank of
chimpanzee and western gorilla specimens previously shown to contain Laverania
parasite DNA(26, 80, 110). These specimens were collected from non-habituated apes
living in remote forest areas, with a two-letter-code indicating their field site of origin as
previously reported (26, 110). DNA was extracted from whole blood and RBCs using the
QIAmp Blood DNA Mini Kit, the Puregene Core Blood Kit (Qiagen), or the NucliSENS
miniMag extraction kit (Biomérieux). All samples were shipped in compliance with
Convention on International Trade in Endangered Species of Wild Fauna and Flora
regulations and country specific import and export permits.

Laverania species identification.
The Laverania species composition of ape blood and fecal samples was determined by
limiting dilution PCR (also termed single genome amplification) and phylogenetic
analysis as previously described (26, 110, 111). Briefly, DNA was endpoint diluted such
that fewer than 30% of PCR reactions yielded an amplification product (according to a
Poisson distribution, a well yielding a PCR product at this dilution will contain only a
single DNA template more than 83% of the time) (111). Amplification products were gel
purified, and sequenced directly without interim cloning. Sequences containing double
peaks, indicative of the presence of multiple templates or early PCR errors, were
discarded. In addition to yielding an accurate representation of the Plasmodium species
present in the sample, this approach generates sequences devoid of Taq polymerase
induced misincorporations and recombination. Samples were analyzed at mitochondrial,
nuclear, and apicoplast loci (Supplementary Tables 1 and 8), including portions of
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cytochrome B (cytB), the erythrocyte binding antigens 165 and 175 (EBA165, EBA175),
the gametocyte surface proteins P47 and P48/45 (P47, P48/45), the lactate
dehydrogenase (ldh), the reticulocyte-binding protein homolog 5 (RH5), the cysteine-rich
protective antigen (CyRPA), members of Phe-Ile-Lys-Lys (FIKK) containing protein
kinase multigene family (FIKK7.2, FIKK14 and FIKK9.15), and the caseinolytic protein C
(clpC) gene. Primers and PCR conditions have been described (26, 80), except for those
used for the amplification of CyRPA and FIKK genes. CyRPA gene fragments (461792bp) were amplified using CyRPA_F1 (5’-TTTYATTTTTTCAAATTGTCTTAGTT-3’)
and CyRPA_R1 (5’-ATGTCTCGCCYTTGTCGTG-3’) in the first round, and CyRPA_F2
(5’-GTCRTCATGTTTTYATAAGGACTG-3’)

and

CyRPA_R2

(5’-

CCATACATAAAATGTCATCCTTCTT-3’) in the second round of PCR, or CyRPA5F1 (5’AAGGACTGARTTRTCGTTYRTAAAG-3’)
AACKTYCCTCCATARCAACCT-3’)

in

and
the

first

TARTGTTCCTTGTRTTSGKGATAT-3’)

round,

and

CyRPA5R1

(5’-

and

(5’-

CyRPA5iF2

CyRPA5iR2

(5’-

ATCMCCYACATAAAAATGAAATGAC-3’) in the second round of PCR. The FIKK7.2
fragment

(637bp)

was

amplified

AAGATTCCTATTARTGCATGGRTAAA-3’)

using
and

FIKK7.2_F993
FIKK7.2_R1782

(5’(5’-

ATGATGGATCAGAACGCTTCC-3’) in the first round, and FIKK7.2_F1061 (5’AAATGCTGAAAATTATGTTATGGAAG-3’)

and

FIKK7.2_R1724

(5’-

GATYCCCAACATATATTTATCAACTG-3’) in the second round of PCR. The FIKK14
fragment

(537bp)

was

amplified

TGAAATGTAGAAGTAGATTAGCAA-3’)

using
and

FIKK14_F1280
FIKK14_R1965

(5’(5’-

GTGTTAAACCTGCTTCATGTAATCTT-3’) in the first round, and FIKK14_F1321 (5’ACTGTATATAATTGGACRTTAGGTAA-

3’)

and

FIKK14_R1884

(5’-

CTAAATCATCATCATCATCATCCATA-3’) in the second round. Finally, the FIKK9.15
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fragment

(730-733bp)

was

amplified

CGGATAGAGATGACGTTTCACA-3’)

using

and

PgSY75FIKK_F1
PgSY75FIKK_R1

(5’(5’-

AAGGCACATGCCTCCATAATA-3’) in the first round, and PgSY75FIKK_F2 (5’ACAGGAGATAATGGAGGAAATGTAG-3’)

and

PgSY75FIKK_R2

(5’-

CCTACCACGTTTACTAAGTCCAATA-3’) in the second round of PCR. For each sample,
multiple single template-derived amplicons were sequenced and their species origin
identified by phylogenetic analysis (see GenBank accession numbers in Supplementary
Table 8). This analysis permitted the identification of samples that represented single (or
near single) Laverania species infections for selective whole genome amplification
(Supplementary Table 1).

Laverania specific real time PCR.
To determine the amount of Laverania DNA within a blood or fecal sample, DNA was
subjected to quantitative (q)PCR using a 7900HT Fast Real-Time PCR System and the
Power SYBR Green qPCR kit (Life Technologies). Laverania specific forward (5’ACATGCCACATGGAAAAGCTT-3’) and reverse (5’-CTGGGGCCTTGGTAAATCCA-3’)
primers were used to amplify a 144 bp fragment of the nuclear ldh gene. PCR cycling
conditions included 2 minutes at 50 °C, 10 minutes at 95 °C, and 40 cycles of 15
seconds at 95 °C and 1 minute at 60 °C. To estimate the number of genome copies per
well,

human

genomic

DNA

containing

known

quantities

of

purified P.

falciparum 3D7 DNA was used to generate a standard curve, which was included on all
qPCR plates (Supplementary Table 1).

Design of SWGA primers.
In contrast to traditional phi29 whole genome amplification methods that use random
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primers to amplify all DNA templates within a sample, selective whole genome
amplification requires primers that bind frequently and evenly across the pathogen
genome, but only rarely to the contaminating host DNA. To identify such primers, we
used a sliding window to determine the frequency of all short sequence motifs (8-12 bp
in length) in both a P. falciparum (3D7) and human (GRCh37) reference sequence and
then calculated the average distance between their locations within these genomes
(Supplementary Fig. 1). This approach identified 2,418 motifs that were spaced apart (on
average) less than 50 kb in the P. falciparum, but more than 500 kb in the human
genome (Fig. 4-1A). To select the best possible primers, motifs with a melting
temperature (Tm) below 18 °C and above 30 °C were discarded because they were
unlikely to properly anneal to the template DNA. Motifs that contained 4 or more
contiguous self-complementary bases were also eliminated to avoid the formation of
homodimers. Finally, motifs predicted to bind greater than 3 times to human
mitochondrial

DNA

were

eliminated,

since

this

circular

genome

would

be

disproportionally targeted by phi29 for “rolling-circle” amplification (75). These criteria
identified 149 potential SWGA primers.
In a previous study, we found that motifs that exhibited the highest target-tonontarget binding ratios were able to mediate selective amplification of bacterial
genomes from infected host DNA (39). However, it was unclear whether this criterion
alone would be sufficient for more complex (multichromosomal) eukaryotic genomes. To
design primers capable of amplifying all regions of the Plasmodium genome, we
developed a metric that scored both selectivity and evenness of coverage. To score a
set of primers, we divided the P. falciparum and human genomes into 10-kb nonoverlapping segments and calculated the proportion of segments that contained at least
one primer-binding site (Supplementary Fig. 1). Since our goal was to identify primer
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binding sites in as many P. falciparum segments as possible, while minimizing segments
containing the same binding site in the human genome, we defined our “set score” as
the difference between the former and the latter (Equation 1). The complete P.
falciparum and human genomes, including telomeric sequence, were used for the
calculation.
!"! =

Proportion of 10-kb sites in P. falciparum genome
containing at least 1 primer binding site

!"! =

Proportion of 10-kb sites in the human genome
containing at least 1 primer binding site
Set Score = !"! − !"!

Equation 1: Scoring metric for SWGA primer sets
Starting with a set of 149 primers, there are a total of 1.2 x 1015 possible combinations of
10 or fewer primers. Since identifying the single best set would be computationally
impossible, we used a heuristic approach to search for optimal primer combinations.
Reasoning that heterodimer formation would reduce amplification efficiency, we divided
the 149 primers into eight mutually exclusive groups, where no two primers contained 4
or more contiguous complementary bases. For each group, we first scored primers
individually (using Equation 1), and selected the highest scoring primer. We then paired
this primer with all other primers and identified the highest scoring pair. This process
was repeated by iteratively adding primers until the set score no longer improved
(Supplementary Fig. 1). Applying this approach to all primer groups generated eight high
scoring sets. The two best sets (6A and 8A) were then tested using human genomic
DNA containing known quantities of P. falciparum DNA (a primer design pipeline that is
applicable to the genomes of other organisms is available upon request).
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SWGA protocol and validation of primer sets.
SWGA was performed as described (39), essentially following previously published
phi29 amplification protocols, but using primers designed to selectively amplify
Laverania genomes (Fig. 4-1). Amplification conditions included a one-hour ramp down
step (35 °C to 30 °C), followed by a 16 hour amplification step at 30 °C. Phi29 was then
denatured for 10 min at 65 °C, and the SWGA product was stored at 4 °C. To validate
the SWGA primers, genomic DNA extracted from cultured P. falciparum (3D7) parasites
and human CD4+ T cells were mixed to generate human DNA preparations containing
5%, 1%, 0.1%, 0.01%, and 0.001% P. falciparum DNA. SWGA was performed in a
volume of 50µl using 50 ng of DNA, 3.5 mM of each SWGA primer (set 6A), 1x phi29
buffer (New England Biolabs), 1 mM dNTPs, and 30 units of phi29 polymerase (New
England Biolabs). 4 ul of the resulting SWGA product was then subjected to a second
round of SWGA using the same amplification conditions, except for using a different set
of primers (set 8A). Each of the human/Pf mixtures was amplified separately and purified
using Agencourt AmpureXP beads (Beckman Coulter). 20 ng of the resulting SWGA
products were used to generate short-insert libraries (Nextera Library Prep Kit) and
sequenced on an Illumina MiSeq, yielding 150 bp paired reads. Enrichment was
quantified by mapping paired reads first to the human and then to the P. falciparum 3D7
genome using SMALT 0.7.6 (https://www.sanger.ac.uk/resources/software/smalt/) and
then calculating the percentage of reads that mapped to P. falciparum 3D7. This
analysis showed that the SWGA method amplified P. falciparum with extraordinary
selectivity, resulting in an up to 70,000-fold enrichment of parasite over host DNA (Table
3-1) while maintaining an even coverage of all chromosomes, except for sub-telomeric
regions where extremely high AT-content precluded accurate mapping (Supplementary
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Fig. 2).
To determine the efficiency of SWGA, we performed a rarefaction analysis,
examining both the selectivity and evenness of amplification for different ratios of
host/parasite DNA. For each human/Pf DNA mixture, subsets of reads were randomly
selected and mapped to the P. falciparum (3D7) and human reference genomes
(GRCh37) simultaneously. The percent of the P. falciparum genome with ≥1x coverage
was then calculated and compared to the expected coverage of the same unamplified
human/Pf mixture (Fig. 4-1C). This analysis showed that the SWGA approach was able
to dramatically decrease the sequencing effort required to obtain broad coverage of the
P. falciparum core genome, with little to no coverage loss when applied to samples
containing <0.01% P. falciparum (Fig. 4-1C).

Selective amplification of P. reichenowi and P. gaboni genomes.
To amplify near-full-length Laverania parasite genomes from unprocessed ape blood, we
selected one chimpanzee sample (SY57) that contained mostly (>99%) P. reichenowi
and two others (SY75 and SY37) that contained exclusively P. gaboni DNA for SWGA
analysis (Supplementary Table 1). Since these samples contained very little Laverania
DNA (0.00081%-0.14%), we first digested them with methylation dependent restriction
enzymes (MspJI and FspEI) to selectively cleave the contaminating host DNA (38).
Briefly, 200ng - 1µg of total DNA were digested with FspEI (5U) and MspJI (5U) for 7
hours at 37 °C, after which the enzymes were heat inactivated. The digestion products
were purified and subjected to two successive rounds of SWGA using the same
conditions as described above. For each chimpanzee sample, SWGA was performed
using multiple DNA replicates (Supplementary Table 1), with half being first amplified
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with primer set 8A followed by primer set 6A, and the other half being first amplified with
primer set 6A followed by primer set 8A. Amplification products were purified, pooled,
and used to generate short-insert libraries (650 bp) using the Illumina TruSeq PCR-Free
Library Preparation Kit (Supplementary Table 1). To facilitate subsequent genome
assembly, we also generated long insert libraries (3 kb, 5 kb, 8 kb and 9 kb) for the P.
gaboni sample SY75 (Illumina Nextera Mate Pair Sample Preparation Kit). All libraries
were sequenced using the Illumina MiSeq and paired reads were first mapped to the
chimpanzee reference genome (Pan_troglodytes-2.1.4) using SMALT. The remaining
reads were then mapped to the Plasmodium genome, with Pf3D7 serving as the
reference for SY75 and SY37, and PrCDC serving as the reference for SY57. Although
SY75 (73%) and SY37 (61%) yielded fewer parasite-specific reads than SY57 (89%),
this was not due to a reduced amplification selectivity, but reflected the difficulty of
mapping P. gaboni reads to the much more divergent P. falciparum genome
(Supplementary Table 1).

Assembly of P. gaboni and P. reichenowi draft genomes.
Draft genomes were generated for the P. reichenowi strain PrSY57 and the P. gaboni
strain PgSY75 using reference guided de novo assembly with post-assembly genome
improvements (69, 81). First, working drafts of the PrSY57 and PgSY75 genomes were
generated by iteratively mapping (non-chimpanzee) reads to the PrCDC and Pf3D7
references,

respectively,

using

Geneious

6

(Biomatters

Limited,

http://www.geneious.com). This mapping process, which was repeated 10 times,
resulted in a sequence that represented the read mapping consensus at all positions
with ≥5 fold coverage. At positions with lower coverage, the sequence of the reference
(Pf3D7 or PrCDC) was used instead. All reads were then re-mapped to this consensus
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using two iterations. The resulting draft reference represented the mapping consensus at
all positions with ≥5 fold coverage, with positions with <5 fold coverage denoted by “N”s.
Prior to de novo assembly, error correction was performed on short-insert
libraries from each sample using String Graph Assembler (SGA 0.10.12) (112) as
previously described (69). For the P. gaboni sample PgSY75, reads were also
normalized using KHMER (113), which uses k-mer frequencies to estimate and
normalize genome coverage in a reference-free manner, thus facilitating subsequent de
novo assembly. This process yielded 11 million reads.
After mapping reads to the working draft reference using SMALT, a reference
guided de novo assembly was generated using the Columbus extension to Velvet 1.1.06
(114). Assemblies were produced using a variety of k-mer lengths and coverage
settings. Comparing these assemblies to the Pf3D7 and PrCDC references, we identified
several tandem duplications, which upon visual inspection were judged to likely
represent assembly errors. We thus changed the assembly parameters to minimize the
number of these duplications. Specifically, we varied k-mer length, coverage cutoff, and
minimum paired coverage, and analyzed the resulting assembly quality by comparing
the length of contigs, maximum node length, total assembly length, and the number of
tandem duplications compared to the reference genome.
For the P. gaboni sample PgSY75, contigs produced by Velvet Columbus were
further scaffolded using long insert libraries with SSPACE 2.0 (115). Scaffolding was
performed iteratively, first using the 3 kb library, then the 5 kb library, and finally the 8 kb
and 9 kb libraries. Scaffolding was performed using default parameters, except for (i) a
minimum number of mate pairs (-k) of 10 for the 3 kb library and 5 for the 5 kb, 8 kb and
9 kb libraries, respectively, (ii) a maximum ratio between the two best pairs (-a) of 0.6,
(iii) a minimum required overlap (-n) of 60 bp, and (iv) a minimum contig size (-z) of 500.
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Scaffolding was not performed for the P. reichenowi PrSY57 because long insert
libraries were not generated for this sample.
To improve the quality of the draft references, contigs and scaffolds produced by
Velvet Columbus and SSPACE were subjected to two iterations of post-assembly
improvement using PAGIT v1 (81). Contigs were aligned against the respective
reference genomes using ABACAS 1.3.1 and joined into a single ordered sequence
separated by gaps (“N”s). The resulting ordering was compared to the reference
genome using blastn to identify erroneously placed contigs. ABACAS parameters for
minimum percent identity (-i) and minimum contig coverage (-v) were varied to maximize
the total number of correctly placed contigs (e.g., -i 90 was used to minimize P. gaboni
contamination in the P. reichenowi SY57 assembly). Contigs were then manually
rearranged in the Artemis Comparison Tool (ACT) (116) to correct any remaining
placement errors. Gaps between contigs were closed using gapfiller 1.10 (117) and
IMAGE 2.4.1 (118). Since the closing of gaps also produced tandem duplications,
parameters for gapfiller and IMAGE were varied to minimize the number of duplications
and maximize the number of gaps closed.
Mapping paired reads to the improved draft genome identified several instances
where Velvet or gap-closure produced erroneously assembled sequence. Since read
coverage is often reduced on both sides of an assembly error, we calculated the mean
read coverage for a 1,750 bp window surrounding these positions (the central 750 bp
which were slightly larger than the library insert size were excluded from these
calculation). We then broke the draft genome into contigs at positions where the
coverage was either below five paired reads or 10% of the mean coverage of the 1,750
bp window, and repeated the process of contig ordering and gap closure using the
broken contigs, varying the same parameters as before.
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The ordered, gap-closed, draft genome produced by PAGIT was corrected using
iCORN 2 (119), which corrects SNP and indel errors based on the read consensus. We
ran iCORN iteratively until no additional corrections of the genome were required. The
final output was designated version 0.1 of both the PgSY75 and PrSY57 draft
chromosomal assemblies, with all additional edits made after manual inspection during
gene annotation and subsequent analyses.

Generation of PgSY75 and PrSY57 unplaced read bins.
All contigs that could not be placed into chromosomal scaffolds of an assembly during
the PAGIT process were put into an unplaced-read-bin (version 0.1). These “bins” were
then expanded using de novo assemblies of (non-chimpanzee) reads that failed to map
to both the chromosomal assembly and the v0.1 bin. This was done by mapping all
reads from PgSY75 and PrSY57 to their respective draft assembly and bin using
SMALT, and then performing de novo assembly of the remaining unplaced read pairs
using SPAdes 3.1.1 (120). SPAdes was run using the default multicellular mode
parameters, except for the k-mer length (-k) that was set to 21, 33, 55, and 77. For
PgSY75, the resulting contigs were corrected using iCORN (119), using only unmapped
read pairs from the previous step and added to the unplaced bin. For PrSY57, the
combined unplaced bin contigs were screened for contaminating P. gaboni sequences
by performing blastn searches to a combined database of PrCDC, Pf3D7 and PgSY75
chromosomes. Contigs were only retained if their best match was to a P. reichenowi
contig, exhibited ≥90% identity, and had e-value ≤10-15. Duplicated contigs, which had
been assembled erroneously due to the presence of inter-strain polymorphisms or
sequencing error, were initially merged by running dipSPAdes (121) on the combined
unplaced contig bins for each draft assembly, using haplocontig mode. Each unplaced
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contig in the reduced bin was then compared to the chromosomal assembly and other
unplaced bin contigs using blastn, and those that were >85% identical to chromosomal
or bin contigs were aligned to their match, visually inspected, and either removed or
used to improve the existing assembly. The resulting de-duplicated bin was combined
with the v0.1 draft chromosomal assembly and designated the v0.1 draft genome.

Annotation of the PgSY75 and PrSY57 draft genomes.
Annotations were transferred to the PgSY75 and PrSY57 draft genomes from P.
falciparum (Pf3D7) and P. reichenowi (PrCDC) reference genomes, respectively.
Annotation transfer was performed using RATT (122) and corrected manually in ACT
(116) using a blastn alignment to the corresponding reference. Genes in the draft
genomes that were not present in Pf3D7 or PrCDC, or had been missed by RATT, were
identified by de novo annotation in Augustus (123) using the Plasmodium falciparum
species configuration. De novo annotations that overlapped transferred annotations
were removed. The remaining de novo annotations were compared with their reference
strains using blastn and tblastx to identify putative orthologs and homologs, and
corrected by visual inspection. Annotations for which no homolog could be identified in
the reference were compared individually with all available Plasmodium genomes, and
deleted if no putative homolog could be found.

Generation and annotation of the PgSY37 draft genome.
Because the small amounts of P. gaboni DNA present in sample SY37 resulted in
greater unevenness of whole genome amplification and sequence coverage, the
PgSY37 draft genome was assembled by iteratively mapping the SWGA generated
sequencing reads to the PgSY75 genome, using the same methods and parameters
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described above. Unplaced reads were assembled using SPAdes (120) and placed into
the PgSY37 unplaced read bin. The PgSY37 genome was annotated by strain level
annotation transfer from the PgSY75 genome using RATT (122), and corrected by visual
inspection.

Limitations of SWGA to generate Plasmodium genome sequences.
SWGA generated high quality Plasmodium genomes when samples were well
preserved, comprised Laverania mono (or near mono) infections, and contained
>0.0005% of parasite DNA. Although even a relatively low parasite load (e.g., 0.0054%
in SY57) yielded broad coverage, coverage depth varied due to the process by which
SWGA enriches for target DNA. Very low levels of parasite DNA (e.g., 0.00081% in
SY37) led to stochastic peaks of amplification scattered across the genome. Moreover,
partial sample degradation impeded SWGA. For example, two gorilla blood samples
(SA3066 and SA3157), which were frozen without preservation, failed to yield genome
sequences following SWGA and MiSeq sequencing, despite the presence of seemingly
sufficient (albeit low level) quantities of parasite DNA (0.00073% and 0.00024%,
respectively). Thus, SWGA requires not only a minimum amount of parasite DNA, but
also

high

molecular

weight

Plasmodium

genomes

for

efficient

amplification.

Nonetheless, the SWGA products of the two gorilla blood samples yielded nuclear gene
fragments (CyRPA, FIKK) when subjected to conventional single template PCR,
indicating selective amplification even of partially degraded parasite DNA.

Genes used in genome-wide analyses.
Syntenic orthologs in P. falciparum 3D7 and P. reichenowi CDC were identified by
chromosomal alignment. After exclusion of (i) var, rif, and stevor gene families, (ii) genes
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that were pseudogenes in at least one of these Laverania species (Supplementary Table
2), (iii) genes that had previously been suggested to be dimorphic in P. falciparum (124,
125) (msp1, msp2, msp3, msp6 and EBA175), and (vi) genes for which orthologs could
not be identified in P. gaboni (Supplementary Data 1), the remaining sets of orthologs
were used for genome-wide analyses. Subtelomeric regions, which were excluded from
P. falciparum polymorphism data, were defined as regions at the ends of chromosomes
that consisted primarily of genes previously annotated as subtelomeric or members of
subtelomeric gene families, including var, rif, stevor, PHIST, mc-2tm, hyp gene families
1-17, resa, lysophospholipase, DNAJ and acyl-coA synthetase. Subtelomeric genes are
identified in Supplementary Data.

Inter-species divergence.
The lengths of coding sequences from the annotated genomes were compared with their
homologs or orthologs in the respective reference sequence (PrCDC for PrSY57, Pf3D7
for PgSY75 and PgSY37). Genes were only included in genome-wide analyses if they (i)
were ≥90% of the length of the reference homolog/ortholog or (ii) were ≥80% of the
length of the reference ortholog/homolog, but also lacked assembly gaps. Each coding
region was translated and queried for amino acid repeats using tblastx. Repeated
sequences were masked if they comprised at least 20 amino acids with at least 95%
identity between repeat units. Low-complexity amino acid sequences were identified in
translations using segmasker (NCBI BLAST+ package) using default settings, and
masked in the corresponding nucleotide sequences. Masked nucleotide sequences were
aligned using TranslatorX (126) and MUSCLE (127). After alignment, any position that
was masked, or contained an assembly or alignment gap, was masked in all sequences.
Pairwise inter-species genetic distances were calculated in R using the ape package
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(128) with the TN93 model of DNA evolution. Genes with unusually high inter-species
distances were manually inspected and corrected if necessary. If the best alignment
required insertion of a gap not divisible by three, the gene was excluded from intraspecies diversity analyses (since these required sequence translations). Inter-species
distances were calculated using all available orthologs for Pf3D7, PrCDC, PrSY57,
PgSY75 and PgSY37.

Intra-species diversity.
For P. falciparum, intra-species diversity was calculated using previously published
parasite sequence datasets (Table 3-3) of geographically diverse field isolates collected
in Bangladesh, Cambodia, DRC, Gambia, Ghana, Guinea, Laos, Myanmar, Nigeria,
Thailand,

Kenya,

and

Vietnam

(Pf3k

1.0

pilot

data

release,

http://www.malariagen.net/data/pf3k-1). For each country, three samples were chosen at
random, reads were mapped to the 3D7 reference, and SNP variant calls were
generated for all P. falciparum strains simultaneously using the GATK 3.1-1
UnifiedGenotyper after indel realignment (129-131). To differentiate true variants from
sequencing or alignment artifacts, 354 variant calls were randomly selected and true
variants identified by visual inspection of the alignments. The GATK values (QUAL, QD,
ReadPosRankSum, Genotype Quality, FS, BaseQRankSum, MQRankSum) were then
compared for each true and artifactual variant, and appropriate cutoffs were selected to
minimize false variant calls. Using only SNPs from the core genome, the number of P.
falciparum strains present in each sample was estimated using estMOI (132), with one
likely mono-infection selected for each country (ERS174561, Bangladesh; ERS050887,
Cambodia; ERS347597, DRC; ERS010044, Gambia; ERS157479, Ghana; ERS042044,
Guinea; ERS174601, Laos, ERS143480, Myanmar; ERS199640, Nigeria; ERS224908,
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Thailand; ERS143467, Vietnam). No Kenyan strain was selected since all available
samples were likely to represent multi-strain infections. After exclusion of subtelomeric
genes, alleles from polymorphic sites were extracted from variant call format (vcf) files
using custom Perl scripts. Sites at which three or more samples had missing data (i.e.
no genotype called) or where the majority genotype was represented by <80% of
mapped reads, were excluded from the analysis; otherwise samples with missing data
were assumed to have the reference allele. Intra-species diversity (π) was determined
by calculating the mean number of differences per site for all pairwise combinations of
11 P. falciparum strains plus the 3D7 reference. Sites masked in 3D7 (see above) were
excluded from intra-species diversity calculations.
For P. gaboni and P. reichenowi, intra-species diversity was calculated from the
alignments used for inter-species genetic distance calculations, using the ape R
package to count the proportion of non-masked sites that differed between the two
strains available for each species (PrCDC and PrSY57 for P. reichenowi, PgSY75 and
PgSY37 for P. gaboni).

Phylogenetic Analyses.
Nucleotide sequences used for phylogenetic analyses were aligned using CLUSTAL W
(133), followed by manual correction when necessary. Regions that could not be
unambiguously aligned were removed from further analyses. Maximum likelihood
phylogenetic analyses were conducted using PhyML (134), with iterative model fitting
(52) based on a class of evolutionary models selected using Modeltest (135). For the
analyses of the FIKK orthologs, pseudogene nucleotide sequences were translated, with
indels corrected and in-frame stops coded as “X”, and the deduced amino acid
sequences were aligned using MUSCLE (127). Based on this alignment, the conserved
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FIKK protein regions were identified. The corresponding nucleotide sequences were
then codon aligned, guided by the amino acid alignment. To eliminate possible
mutational saturation at third codon position sites, these were removed prior to
phylogenetic analyses using PhyML.
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4.1 Abstract
Antigens encoded by the var gene family are major virulence factors of the human
malaria parasite Plasmodium falciparum, exhibiting enormous intra- and inter-strain
diversity. Here we use network analysis to show that var architecture and mosaicism are
conserved at multiple levels across the Laverania subgenus, based on var-like
sequences from eight single-species and three multi-species Plasmodium infections of
wild-living or sanctuary African apes. Using select whole-genome amplification, we also
find evidence of multi-domain var structure and synteny in Plasmodium gaboni, one of
the ape Laverania species most distantly related to P. falciparum, as well as a new class
of Duffy Binding-Like (DBL) domains. These findings indicate that the modular genetic
architecture and sequence diversity underlying var-mediated host-parasite interactions
evolved prior to the radiation of the Laverania subgenus, long before the emergence of
P. falciparum.
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4.2 Introduction
Wild-living apes in Africa are naturally infected by at least six Plasmodium species that
form a separate subgenus, termed Laverania (12, 25, 27-32, 110, 136). Three of these
species, P. reichenowi, P. gaboni, and P. billcollinsi, have been found only in
chimpanzees, while the other three, P. adleri, P. blacklocki, and P. praefalciparum, have
been found only in gorillas (Fig. 4-1A). Zoonotic transfer has occurred at least once,
when a gorilla parasite (P. praefalciparum) gave rise to human P. falciparum, which
causes the vast majority of malaria-associated morbidity and mortality in humans (32,
110).
A key component of P. falciparum virulence is the parasite’s ability to cause
infected erythrocytes to adhere to the vascular endothelium. This allows the parasite to
escape elimination in the spleen but can also lead to vascular obstruction and
inflammation, key components of severe pathological complications such as cerebral
malaria (137, 138). Cytoadherence is mediated by members of the P. falciparum
Erythrocyte Membrane Protein 1 (PfEMP1) family, which contain between 3 and 8
different Duffy Binding Like (DBLα-ζ) and Cysteine-rich Interdomain Region (CIDRα-δ)
domains and are expressed on the surface of infected erythrocytes, where they bind to
endothelial receptors. Each P. falciparum genome encodes approximately 60 different
PfEMP1 proteins, which are expressed from var genes, one at a time, by means of
epigenetic regulation (139, 140). Given their central role in P. falciparum pathogenesis,
but absence from all other human Plasmodium species, the origins of var genes are of
particular interest.
Three factors have limited our ability to investigate the evolutionary history of var
genes. First, obtaining blood samples from Laverania-infected wild-living apes is not
ethical. As a result, all ape derived var sequences analyzed to date come from a single
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P. reichenowi parasite, called PrCDC, from a wild-born chimpanzee, who was found to
be Plasmodium infected in captivity (69). Second, P. falciparum var genes are highly
diverse (Fig 4-1B). Not only is there rapid recombination between genes within and
across chromosomes, which shuffles gene content within genome repertoires during
infection (141, 142), but sexual reproduction in the mosquito vector also generates
diversity via reassortment of chromosomes and conversion events (143). Thus,
conventional phylogenetic approaches fail to resolve evolutionary relationships between
var genes, requiring new and recombination-tolerant analysis techniques (144-149).
Finally, the mosaicism and diversity generated by rapid recombination (141, 142),
combined with the fact that most var genes are subtelomeric, render the assembly of
full-length var genes from shotgun sequenced parasite genomes extremely difficult (35,
150).

74

a

P.vivax human
P.vivax ape
P.simiovale
P.fieldi
P.inui
P.hylobati
P.cynomolgi
P.coatneyi
P.fragile
P.knowlesi
P.gonderi
P.malariae
P.ovale
P.yoelii
P.chabaudi
P.reichenowi
P.praefalciparum
P.falciparum
P.billcollinsi
Laverania
P.blacklocki
P.gaboni x
P.adleri
P.mexicanum
P.juxtanucleare
P.gallinaceum
P.floridense

*

Primate parasite
group 1

Rodent parasites

*

*

Primate parasite
group 2

*
*

Bird/reptile
parasites

0.01

1
2
3
4

5

blocksharing
(conservation)

var repertoire
~60 different var genes

•
•
•

~60

NTS

b

domain 1
DBLα

domain 2
CIDR

...

TM

ATS

typical multidomain
composition of var gene
alternating conserved-variable
architecture of DBLα domain

HB3

HB5

Highly Variable
Regions

HB2

PCR tag

Figure 4-1. Characterization of Laverania var gene sequences.
(A) Phylogeny of Plasmodium species. The tree was constructed from mitochondrial
sequences (2.4 kb spanning cox1 and cytB). The scale bar indicates 0.01 substitutions
per site. Colors indicate species infecting humans (red), chimpanzees (purple) and
gorillas (aqua). Asterisks indicate successful PCR amplification of var sequences; a
cross indicates identification of var-like genes in near full-length P. gaboni genomes. (B)
Three-level schematic of modular var diversity, structure, and architecture. Colored ovals
represent classes of DBL or CIDR domains. White boxes represent the N terminal
segment (NTS), transmembrane (TM), and acidic terminal segment (ATS) domains; a
wedge between TM and ATS domains indicates the intron that separates the two var
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exons. Alternating conserved-variable architecture is illustrated using blocksharing (see
Methods) between one representative DBLa domain (DD2var11) and other DBLa
domains (144). A black bar indicates the location of the PCR amplified DBLa tag region,
which spans three conserved homology blocks (HB3, HB5, and HB2) (144), 72 to 147
base pairs in length.

Here we overcome these impediments by generating 369 new var sequence
fragments from five ape Laverania species, derived by PCR amplification from fecal and
blood samples of naturally infected wild-living and sanctuary apes, respectively. We use
network approaches and other recombination-tolerant methods to analyze these new
sequences, together with 353 previously reported var gene sequences from one P.
reichenowi and seven P. falciparum isolates (69, 144). In addition, we identify and
analyze partially assembled var-like sequences from otherwise near-full-length genomes
of two P. gaboni parasites (SYpte37, SYptt75), one of the Laverania species most
distantly related to P. falciparum (39, 151). Analysis of these sequences reveals that
several PfEMP1 domains, as well as the genetic structure and multi-domain architecture
that are characteristic of P. falciparum var genes, are present across the Laverania
subgenus. Thus, many var multi-gene family features predate the most recent common
ancestor of extant Laverania species.

4.3 Results
Laverania species identification and sequence generation
To study var gene architecture in ape Laverania species, we first determined the
Plasmodium species composition of eleven blood and fecal samples from sanctuary and
wild-living apes using a limiting dilution PCR approach called single genome sequencing
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(SGS) (111). To ensure amplification of single parasite templates, blood and fecal DNA
was diluted such that fewer than 30% of all PCR reactions yielded an amplification
product. Amplicons were sequenced directly without cloning into a plasmid vector and
sequences containing ambiguous bases indicative of template mixtures were discarded.
This approach eliminates Taq polymerase-induced recombination (template switching)
and nucleotide misincorporations in finished sequences, and also ensures a proportional
representation of plasmodial variants as they exist in vivo (see Methods for a more
detailed description of SGS). Targeting eight different mitochondrial, apicoplast and
nuclear loci and sequencing up to 174 different SGS amplicons per sample
(Supplementary Table 1), we identified eight samples with single-species infections of P.
reichenowi (C1), P. gaboni (C2), P. billcollinsi (C3), or P. praefalciparum (G1). Three
additional fecal samples represented mixed-species infections of several gorilla or
chimpanzee parasites, including one of unknown, non-Laverania species origin
(Supplementary Table 1).
Given their enormous diversity, var homologs were amplified targeting a
conserved region of the DBLa domain, termed the var gene “tag”, using conventional
PCR and previously reported primers (152, 153) (see Methods and Supplementary
Table 2). Amplicons were cloned, and multiple clones per sample were sequenced and
grouped into unique haplotypes by phylogenetic analysis. The var gene tag is commonly
analyzed because it is sufficiently conserved in two locations to allow reliable
amplification, and is located within the DBLα domain, which, unlike other DBL domains,
is present in almost all var genes (145-147, 152-154). The DBLα tag consists of three
conserved homology blocks (144) (HBs) interspersed with highly variable regions
(HVRs) of diverse length and sequence content (Fig. 4-1B), an architecture that
facilitates mosaicism (146). Standard sequence analysis techniques can not adequately
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analyze these mosaic sequences (144-149) and we therefore used a network analysis
method to characterize the evolutionary relationships between Laverania var fragments.
Figure 4-2 illustrates this type of analysis, where each node represents a var DBL
sequence tag and a link between two nodes represents a shared identical sequence
mosaic element. Due to frequent recombination and the possibility that immune selection
differs between adjacent HVRs, networks were constructed independently for each of
the two HVRs, which in P. falciparum were shown to exhibit different community
structures (146). For each sample, only unique var tag haplotypes were included into the
analysis (see Methods for a detailed description of network construction and statistical
community detection).

Shared var mosaic structure in P. reichenowi and P. falciparum
We first examined the 37 new DBLα var tags from a P. reichenowi monoinfection
detected by routine blood analysis in an asymptomatic sanctuary chimpanzee (SYptt15),
who was housed in close proximity to the habitat of wild apes. It is well established that
human P. falciparum and chimpanzee P. reichenowi are closely related sister taxa (69),
and previous analyses of PrCDC var gene sequences indicated sequence homology
with field and lab strains of P. falciparum (69, 145, 147, 148, 155). While early studies
investigated shared polymorphisms in preliminary assemblies of a small subset of these
genes (145), more recent studies analyzed the complete set of PrCDC DBLα domains,
finding conserved gene regions between PrCDC and P. falciparum isolates 3D7 and
HB3 (148) as well as the presence of P. falciparum homology blocks in PrCDC DBLα
sequences (155). In contrast, we focused specifically on the most polymorphic HVR
regions of P. falciparum and P. reichenowi DBLα homologs. Using a network community
detection algorithm, a Bayesian k-mer analysis, and a pair-wise distance approach, we
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found that var mosaics within the P. falciparum-P. reichenowi network do not cluster by
parasite species (Fig. 4-2, Supplementary Fig. 1A,B), and that var genes from both
species exhibit the same modular HVR architecture, i.e., a pattern of alternating regions
of conservation and variability (Supplementary Fig. 1C). We have previously
hypothesized that this genetic structure may allow for neighboring HVRs to respond
independently to different selection pressures (146). Thus, our results confirm and
extend previous findings that DBLα organization and capacity for diversification in
response to immune selection were already present in the most recent common
ancestor of P. falciparum and P. reichenowi.
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Figure 4-2. Networks of DBLα sequences from P. reichenowi and P. falciparum.
Each node represents a DBLα HVR sequence and each link represents a shared amino
acid substring of significant length (146). Laverania species and strain origin is indicated
by node color and shape. Left and right networks correspond to left and right HVRs,
respectively. P. falciparum and P. reichenowi sequences do not cluster by species or
sample in either HVR. Link lengths and node placements are determined by a forcedirected layout in order to better reveal structure, if it exists (see Methods). Additional
analyses of these networks are shown in Supplementary Figure 1.

var DBLα tag structures predate the Laverania radiation
Having analyzed var tags from P. falciparum and P. reichenowi, we next examined
parasite sequences from across the ape Laverania subgenus. Numerous identical
mosaic elements in otherwise divergent sequences and a shared overall HVR
architecture extended to the most divergent species (Fig. 4-3 and Supplementary Fig. 2).
We were able to reconstruct highly connected networks for each HVR, indicating the
presence of shared mosaic elements among the vast majority of tags from singlespecies parasite infections. Every Laverania var tag contained three conserved
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sequence motifs separating two HVRs: in 86% of sequences, the three conserved motifs
corresponded to three of the five most common P. falciparum var motifs (in order: HB3,
HB5, HB2) (144), while in the remaining 14%, HB5 was intact in the middle of the tag
and more divergent forms of HB3 and HB2 were encoded by the 5’ and 3’ end of the tag,
respectively (Supplementary Fig. 3).
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Figure 4-3. Networks of DBL sequences from Laverania single-species infections
in the context of known DBLα and non-DBLα sequences.
Each node represents a DBL HVR sequence from a single-species infection and each
link represents a shared amino acid substring of significant length. Note that for each
sample, only unique var DBL haplotypes were included in the network analysis. Nodes
with zero links indicate sequences that share no significant amino acid substrings with
other sequences. Networks were built separately for each HVR, where mosaic diversity
is highest (see Methods). Colors correspond to Laverania species as indicated;
annotated yellow nodes correspond to (A) dblsmsp1 and (B) dblmsp2 from Pf3D7, PfIT,
and PrCDC; (C) both DBL domains from ebl1, eba140, eba165, eba175, eba181 of
Pf3D7 and PfIT; (D) P. vivax Duffy Binding Proteins; see Supplementary Table 3 for a
comprehensive list of non-DBLa sequences.
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We confirmed that these tags were not derived from non-var DBL-containing
genes by including tags from P. falciparum Erythrocyte Binding Antigen (eba) genes, P.
falciparum and P. reichenowi DBL Merozoite Surface Protein 1 (msp3.4) and DBLMSP2
(msp3.8), and P. vivax Duffy Binding Proteins in our analysis (Supplementary Table 3).
We also included P. falciparum DBLε tags to compare tags to var-derived, yet nonDBLα, sequences. As shown in Fig. 4-3, tags from single-species ape Laverania
infections remained separated from both the non-var DBL tags and the P. falciparum
DBLε tags, with a majority connected to one or both of the large connected components
formed by the P. falciparum and known P. reichenowi tags. This majority included every
new P. reichenowi and P. praefalciparum tag, and all but one P. billcollinsi tag. On the
other hand, only 10 P. gaboni tags were connected to one or both large components,
with the other 26 connected only to other P. gaboni tags in separate, small components.
These smaller P. gaboni components did not share mosaic elements with DBLε and
non-var DBL sequences, suggesting that they represented divergent, yet var-like,
domains.

Laverania parasites contain ape-specific var-like DBL domains
We next investigated the relationships between sequences from all ape Laverania
samples by conducting a network analysis that excluded P. falciparum, but included
sequences from both mixed-species and single-species infections (Fig. 4-4). Sequences
from P. billcollinsi and P. praefalciparum remained integrated within the large connected
component that also included P. reichenowi, indicating conservation of mosaic elements
within HVRs across these species. This finding is consistent with mtDNA (Fig. 4-1A),
apicoplast, and nuclear phylogenies (110, 156), which place P. billcollinsi and P.
praefalciparum closer to P. reichenowi. In contrast, sequences from four single-species
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infections of P. gaboni, which represent a much more distant Laverania species,
exhibited much less shared sequence content in HVR networks. However, P. gaboni
sequences appeared to fall into two subgroups based on tag length: (i) longer P. gaboni
sequences (94-135 amino acids), which share mosaic elements with P. reichenowi and
P. billcollinsi in 8 of 15 sequences in the Left HVR and 2 of 15 sequences in the Right
HVR, and which we therefore term DBLα-like (red, unboxed in Fig. 4-4); and (ii) shorter
P. gaboni sequences (72-85 amino acids), which remain disconnected from the P.
reichenowi-P.billcollinsi component in 21 of 21 cases and which we therefore termed
DBLx-like (red, boxed in Fig. 4-4). Thus, within the HVRs, longer P. gaboni DBLα-like
sequences are partially overlapping with P. reichenowi and P. billcollinsi, while the
shorter sequences appear to be distinct.
Although the DBLx tags fell outside the large connected component of the P.
reichenowi-P. billcollinsi network group (Fig. 4-4, boxes), they were all amplified using
standard P. falciparum DBLα primers, and they all exhibited the classical DBL
architecture with fully intact HB5 motifs in the tag center. However, they were unrelated
to other known DBL domain classes (Supplementary Fig. 4). All four single-species P.
gaboni samples, as well as one P. gaboni-containing mixed-species sample, contained
DBLx sequences. Based on polymorphisms in the HB3-like region, DBLx sequences
formed two subgroups, which we refer to as DBLx1 and DBLx2 (Supplementary Fig. 3,
Methods). DBLx sequences were not limited to chimpanzee parasites, as the mixedspecies infection gorilla sample GTggg118, which contained both P. praefalciparum and
P. adleri, also featured DBLx2 tags. The GTggg118 DBLx2 tags shared mosaic
elements with both DBLx1 and DBLx2 tags from P. gaboni, while the GTggg118 DBLαlike tags were well-connected to the P. billcollinsi-P. reichenowi component (Fig. 4-4).
We thus hypothesize that the GTggg118 DBLx2 tags derive from P. adleri, a closely
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related sister taxon to P. gaboni (Fig. 4-1A), while the DBLα-like tags may be derived
from either P. adleri or P. praefalciparum. Thus, it is likely that DBLx sequences
represent new var-like DBL subdomains that are restricted to the C2/G2 branch of the
Laverania subgenus (Fig. 4-1A).

Figure 4-4. Networks of DBL sequences from single- and multi-species Laverania
infections.
Each node represents a DBL HVR sequence and each link represents a shared amino
acid substring of significant length. Note that for each sample only unique var DBL
haplotypes were included in the network analysis. Nodes with zero links indicate
sequences that share no significant amino acid substrings with other sequences.
Networks were built separately for each HVR, where mosaic diversity is highest (see
Methods). Circular nodes represent chimpanzee parasites and square nodes represent
gorilla parasites. Node color corresponds to species and node size corresponds to tag
length as indicated. DBLx sequences are enclosed in boxes.
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var multi-domain structures predate the Laverania radiation
To confirm the presence of var-like genes in P. gaboni, we also examined near fulllength parasite genomes and unplaced contigs, which were derived by select whole
genome amplification (SWGA) (39) from two chimpanzee blood samples (SYpte37 and
SYptt75). Three lines of evidence indicated that var-like genes, consisting of multiple
DBL domains, were indeed present in this parasite species. First, we identified 55 varlike DBL domains in 40 different contigs, 14 and 2 of which were further classified using
the VarDom server (144) as being related to P. falciparum DBLε and DBLζ domains,
respectively (Table 1, Methods). None of the remaining DBL domains could be similarly
subclassified, but four contigs featured exact nucleotide matches for DBLα-like tag
sequences, providing a cross-validation between methods. Three contigs featured 3, 4,
and 5 adjacent and non-identical DBL domains, a configuration unique to vars. An
additional six contigs featured two adjacent DBL domains, but in these cases an eba
gene origin could not formally be excluded (157).

Table 4-1 Var gene-like structures in P. gaboni whole-genome contigs

Sample

Total varlike DBLs
identified

SYpte37

15

SYptt75

40

number of DBLs (number of contigs)
1DBL
8 (8)
23
a
(23 )

2DBL

3DBL

4DBL

5DBL

DBL classification

b

DBLε

DBLζ

unclassified

var-like
ATS

4 (2)

3 (1)

-

-

2

-

13

0

8 (4)

-

4 (1)

5 (1)

12

2

26

16

a

includes the three-exon single-DBL containing contig shown in
Fig. 4-6.
b
DBLa-δ domains according to the classification by Rask et al.,(144) were not
identified. In addition, we found no evidence of DBLa-CIDR domain pairs.
c
Includes three contigs with var-like DBL-TM^ATS multi domain
(two-exon) structure
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c

The finding of only nine contigs with var-like multi-DBL configurations in our P.
gaboni genomic data is likely related to difficulties in assembling these sequences from
short read data. De novo assembly is hindered by identical and near-identical motifs
present in different DBL domains, which makes an accurate determination of the number
and order of these domains in a given var gene difficult (158). In contrast, acidic terminal
segment (ATS) domains, which are also a unique feature of var genes, lack these repeat
structures, although they share some sequence motifs due to frequent recombination
(159). We thus reasoned that ATS regions would more likely assemble into full length or
near full-length domains and looked for these var signatures in the P. gaboni genomic
sequences. Indeed, ATS domains were readily identified in 16 contigs derived from the
P. gaboni SYptt75 genome. In P. falciparum, the ATS domain encodes the intracellular
portion of the PfEMP1 protein, which is expressed from a separate exon (Fig. 4-1B).
ATS domains are unique to var genes, except for a single copy non-var gene with an
“ATS-like” domain on chromosome 1 (PF3D7_0113800) (144). Using the VarDom server
to characterize the P. gaboni ATS domains, we identified seven of ten known major
homology blocks (Fig. 4-5). These were very similar to P. falciparum var ATS homology
blocks, but very different from the non-var “ATS-like” domains of PF3D7_0113800 and
its P. reichenowi, and P. gaboni orthologs (Fig. 4-5, Supplementary Fig. 5), thus
providing compelling evidence for the presence of bona fide var ATS domains in P.
gaboni.
Finally, three of the ATS-containing contigs exhibited a longer two-exon var gene
structure, with a DBL and trans-membrane (TM) domain in exon 1 and an ATS domain
in exon 2. One of these contigs contained an additional open reading frame (ORF)
downstream of the var-like exon 2, which was 88% identical in its nucleotide sequence
to genes and intergenic flanking sequences in P. falciparum (PF3D7_0323800) and P.
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reichenowi (PRCDC_0323100) on the same chromosome, respectively (the latter two
shared 94% nucleotide sequence identity). Although the function of these orthologs is
unknown, they are single-copy genes immediately adjacent to a var exon 2 pseudogene
on chromosome 3 of both P. falciparum and P. reichenowi (Fig. 4-6). This synteny
implies the existence of ancestral ORFs on chromosome 3, including a var gene that
retained both exons in P. gaboni, but represents a single-exon pseudogene in P.
falciparum and P. reichenowi. Thus, the presence of a two-exon var structure and
synteny on chromosome 3 for three Laverania species, which span the root of the
subgenus phylogeny, indicate that var genes evolved their extant two-exon and multidomain structure prior to the radiation of this subgenus.
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Figure 4-5. Conservation of var ATS domain homology block structure in P.
gaboni.
The homology block (HB) structure of var ATS domains identified in 16 contigs of a near
complete P. gaboni genome (PgSY75) are shown in relation to representative P.
falciparum and P. reichenowi var ATS domains (Pf3D7 and PrCDC1, top) as well as a
non-var “ATS-like” domain of the P. falciparum PF3D7_0113800 gene and its P.
reichenowi and P. gaboni orthologues (bottom). HBs (arrows) were predicted by VarDom
1.0 and annotated in an alignment of all 20 sequences. Colors correspond to VarDom
reported E-values, representing an estimate of the likelihood of observing such a match
by random chance. Black lines indicate the relative length of each sequence.
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Figure 4-6. Shared synteny of var-like genes in P. falciparum, P. reichenowi and P.
gaboni.
An open reading frame (ORF) located downstream of a predicted var-like gene in P.
gaboni showed 88% sequence identity (dark grey bars) with a single copy gene present
in

both

P.

falciparum

3D7

(PF3D7_0323800)

and

P.

reichenowi

CDC1

(PRCDC_0323100). The P. gaboni var-like gene is syntenic with a var exon 2
pseudogene in both P. falciparum and P. reichenowi, suggesting that a var gene was
present at this location in the ancestor of all three Laverania species.

Laverania var repertoire structure
It has previously been shown that P. falciparum var genes can be divided on the basis of
DBLα domains into two main groups, classified by the number of cysteine residues in the
tag region (152) which map to distinct community structures in network analyses (146).
These two main groups can be further subdivided into a total of six Cys/PoLV (CP)
groups based on the presence or absence of key amino acid residues (152, 160). These
cysteine-based classifications were found to be associated with different upstream
promoter regions and clinical outcomes, and var repertoires in individual P. falciparum
parasites appear to be stably structured with respect to these categories (154). We
observed the same cysteine-based organization, both with respect to cysteine counts
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and CP groups, in DBLα tags from P. billcollinsi, but not from P. gaboni, although in the
latter case we identified far fewer DBLα-like motifs (Supplementary Fig. 6). Thus,
cysteine-based organization of var gene repertoires extends to P. billcollinsi, but may not
extend to P. gaboni (and by inference P adleri).

4.4 Discussion
Until recently, the only known close relative of P. falciparum was P. reichenowi, a
Laverania parasite infecting chimpanzees. Over the past 5-6 years, five additional
species within the Laverania subgenus have been described, each infecting either
chimpanzees or gorillas. This Laverania species diversity provides an unprecedented
opportunity to study the origins of genomic features that previously seemed unique to
P. falciparum, such as the var gene family encoding erythrocyte membrane proteins.
Here we show that various aspects of the multi-scale modularity of these loci can be
recognized in diverse Laverania species, with the implication that a var or var-like gene
family already existed in their last common ancestor. First, at the var gene repertoire
level, we find genes with a characteristic two-exon structure, encoding multiple adjacent
domains potentially capable of binding diverse endothelial markers. Like the constituent
domains of the P. falciparum-encoded PfEMP1 proteins, the other Laverania DBL
sequences can be subclassified into distinct groups, which may reflect differences in
endothelial binding or other specificities. Second, at the domain architecture level,
alternating conserved and hypervariable regions enable combinatorial diversity while
presumably maintaining protein structure and binding functions. Finally, at the
microscale level, some protein motifs within hypervariable regions are shared among
even the most divergent Laverania species, despite the evidence of high frequency
recombination within species. Thus, many key elements of the var multi-gene family
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appear to have originated many (perhaps tens of) millions of years ago.
In P. falciparum, the var-encoded PfEMP1 proteins play a key role in
pathogenesis by mediating the binding of infected red blood cells to specific host
receptors in a wide range of tissues. Particular disease syndromes have been
associated with individual DBL domains, two of which were present in P. gaboni. The
first, DBLε, is found in the var2csa genes of P. falciparum (144) and P. reichenowi,
which exist as only one or two var variants per genome and have been identified in
every complete var repertoire analyzed to date. In P. falciparum, var2csa genes are
responsible for placental binding, and the DBLε domain has thus been implicated in
pregnancy-associated malaria (161). Similarly, we identified DBLζ in P.gaboni. Although
there currently are no host receptors or disease syndromes that have been associated
with this individual domain in P. falciparum, triplet combinations of DBLε and DBLζ
domains have been linked to IgM-positive rosetting phenotypes (162). The presence of
recognizable DBLε and DBLζ domains in the most divergent Laverania species suggests
that DBL domain differentiation into subtypes represents an ancient host adaptation, and
that DBLε and DBLζ may represent functionally constrained domains across the
Laverania subgenus.
Beyond single var domains, the var repertoires of P. falciparum parasites can be
divided into groups that have been associated with different clinical phenotypes, such as
severe malarial anemia and cerebral malaria, using a cysteine-based classification of
DBLα tags (160, 163, 164). These groups are represented in similar proportions across
P. falciparum and P. reichenowi parasites, and our data suggest that this repertoire
structure may also extend to P. billcollinsi (Supplementary Fig. 6); an insufficient number
of DBLα-like tags precludes an extension of this classification to P. gaboni at the present
time. Given their association with clinical disease in humans, the extent to which these
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sequence features are also indicative of pathology in apes warrants further study.
Although we identified var-like features in species spanning the Laverania
subgenus, we also found that certain signatures identified in P. falciparum and P.
reichenowi var genes are absent from the more divergent parasite species. For example,
we found no evidence of CIDR domains in either of the P. gaboni genomes, despite
identifying numerous DBL domains (Table 1). Moreover, DBLα-like P. gaboni sequences
were not sufficiently similar to P. falciparum DBLα domains to be confidently classified
as such. Since the vast majority of P. falciparum var genes encode a DBLα-CIDR
domain pair, the apparent absence of CIDR domains from P. gaboni is puzzling,
especially in light of the role that CIDR domains are believed to play in host receptor
binding (165). It will be important to determine whether P. gaboni var-like genes contain
other domains with CIDR-like function or whether P. gaboni differs in its biology from
other Laverania parasites. Second, the network analysis of PCR tags revealed new DBL
domains that we termed DBLx because they are unlike the other six known var DBL
domain classes shared by P. falciparum (166) and P. reichenowi (69) (Fig. 4-4,
Supplementary Figs. 3 and 4). These DBLx tags, which were amplified using P.
falciparum DBLα primers, are shorter than all other tags, and can be further subdivided
into DBLx1 and DBLx2 subgroups based on differences in the highly conserved HB3-like
region (Supplementary Fig. 3). Divergence from the P. falciparum “LARSFADIG” motif
within this HB3-like region have also been reported for another partially characterized P.
gaboni genome (69), but adjacent sequences were not analyzed, thus leaving their
relationship with DBLx domains unknown. Finally, we identified multiple copies of P.
gaboni ATS domains, which exhibit a var-like homology block structure that is very
similar, but not identical, to P. falciparum and P. reichenowi ATS domains (Fig. 4-5,
Table 1, Supplementary Fig. 5). Taken together, these data indicate that, while var-like
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genes in P. gaboni (and possibly also P. adleri) share important structural similarities
with those of P. falciparum and P. reichenowi, they also exhibit important differences,
which may reflect differences in function and biology.
The presence of var-like genes throughout the Laverania subgenus suggests an
ancient adaptation for antigenic variation, and potentially cytoadherence. However, while
links exist between var expression and clinical disease in humans, the disease causing
potential of var-like gene products in Laverania parasites infecting wild apes remains
unknown. Nonetheless, there may be important parallels since recent field studies of
habituated chimpanzees in the Tai Forest, Côte d’Ivoire revealed higher fecal parasite
burdens in both young (167) and pregnant (168) individuals, similar to what has been
described in humans. Given the role of the var-encoded PfEMP1 proteins to mediate
endothelial binding in the presence of a vigorous host immune response, it is likely that
var genes play a similar role in other Laverania species. However, the extent of var gene
diversity, especially among the more divergent Laverania species that lack certain P.
falciparum-specific DBL and CIDR domains, suggest potentially different biological
solutions. Additional field studies of habituated ape populations will be necessary to
establish the biological consequences of ape Laverania infections and the pathogenic
potential of their var-like gene products.

4.5 Methods
Sample collection
Ape fecal samples were collected from wild-living central (Pan troglodytes troglodytes;
DGptt540) and eastern (P. t. schweinfurthii; KApts1680) chimpanzees and western
lowland gorillas (Gorilla gorilla gorilla; GTggg140, GTggg118) for previous molecular
epidemiological studies of Laverania parasites (26). Samples were collected in RNAlater
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(1:1 vol/vol), transported at ambient temperatures, and stored at -80°C. We also
analyzed left-over blood samples from chimpanzees cared for at the Sanaga-Yong
Rescue Centre (SYptt5, SYptt15, SYptt20, SYpte37, SYptt75, SYptt79, SYptt82), which
were obtained in the context of routine health examinations or for specific veterinary
purposes. Samples were shipped in compliance with Convention on International Trade
in Endangered Species of Wild Fauna and Flora regulations and country-specific import
and export permits. DNA was extracted from fecal and blood samples using the QIAamp
Stool DNA Mini Kit and QIAamp Blood DNA Mini Kit (Qiagen, Valencia, CA) respectively,
described in detail in (110).

Plasmodium species identification
The Plasmodium species composition in ape fecal and blood samples was determined
by single genome sequencing (SGS) and phylogenetic analysis (26, 110). Briefly, fecal
and blood DNA was endpoint diluted in 96-well plates, and the dilution that yielded fewer
than 30% wells with positive PCR reactions was used to generate between 2 and 174
different SGS sequences per sample (according to a Poisson distribution, the DNA
dilution that yields PCR products in no more than 30% of wells contains one amplifiable
template per positive PCR more than 83% of the time). Amplification products were gel
purified, and sequenced directly without interim cloning. Sequences that contained
double peaks as an indicator of more than one amplified template were discarded.
Different genomic loci were amplified, including portions of mitochondrial (cytochrome
B), nuclear (erythrocyte binding antigens eba165 and eba175, 6-cysteine protein p47
and p48/45, lactate dehydrogenase, reticulocyte-binding protein homolog 5), and
apicoplast (caseinolytic protease C) genes. All relevant primers are provided in
Supplementary Table 4. For each genomic region, up to 73 single template-derived
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amplicons were sequenced and their species origin was identified by phylogenetic
analysis (Supplementary Table 1). This analysis identified seven blood samples and one
fecal sample to represent single-species infections of P. reichenowi (SYptt15, 46 SGS
sequences), P. gaboni (SYptt5, 86 SGS sequences; SYpte37, 59 SGS sequences;
SYptt75, 122 SGS sequences; SYptt82, 59 SGS sequences), P. billcollinsi (SYptt20,
174 SGS sequences; SYptt79, 16 SGS sequences), and P. praefalciparum (GTggg140;
2 SGS sequences), although many of these specimens contained multiple variants
(haplotypes) of the respective species. Three other fecal samples (GTggg118,
KApts1680, and DGptt540) contained more than one ape Laverania species, and one
included an additional non-Laverania species of unknown origin (Supplementary Table
1).

PCR amplification of var genes
DBL domains were amplified, cloned and sequenced (see (145, 152, 153)) using
conventional (rather than limiting dilution) PCR. Different primers sets, listed below, were
used to amplify 2.5µl of fecal or blood derived DNA in a 25µl reaction volume, containing
0.5µl dNTPs (10mM of each dNTP), 10pmol of each primer, 2.5µl PCR buffer, 0.1µl BSA
solution (50mg/ml), and 0.25µl expand long template enzyme mix (Expand Long
Template PCR System, Roche). Most samples were subjected to single round
amplification

with

previously

published

GCACGAAGTTTTGCAGATATWGG-3’)

primers,
and

including

DBLα-5’

DBLα-3’

(5’(5’-

AARTCTTCKGCCCATTCCTCGAACCA-3’)(153), or DBLαAF’ (5’ GCACGMAGTTTYGC
-3’) and DBLαBR (5’-GCCCATTCSTCGAACCA-3’)(152). Only 3 samples were amplified
with

additional

primers,

including

C1DBLαAF’
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(5’-GCACGVAGTTTTGC-3’)

and

C1DBLαBR

(5’-GCCCATTCSTSGAACCA-3’),

AARTAHAGTTTTGCTGATTTARG-3’)

and

and

C2DBLAF
C2DBLAR

(5’(5’-

TTCGGACCATTCGKCWAWCCA-3’), respectively, or by nested PCR. The C2DBLAF
and C2DBLAR primers were designed to specifically amplify P. gaboni DBL tags using
an alignment of select whole-genome amplification (SWGA) derived contigs of SYpte37.
Cycling conditions included an initial denaturing step of 2 minutes at 94°C, followed by
35-60 cycles of denaturation (94°C, 10 sec), annealing (50-55°C, 30 sec), and
elongation (68°C, 1min), followed by a final elongation step of 10 minutes at 68°C. Both
single round and nested PCR derived amplicons were gel purified and subcloned into
pGEM-T Easy (Promega) or PCR4 TOPO (Life Technologies) plasmid vectors. Positive
clones were sequenced, and analyzed using SEQUENCHER (Gene Codes Corporation,
Ann Arbor, MI) or Lasergene (DNASTAR) software.

Criteria of var gene sequence selection
Amplified var DBL sequences were inspected for primer sequences (which were
removed from final sequences) and the presence of a single intact open reading frame
(ORF); sequences lacking an intact ORF or identifiable 5’ and 3’ primer sequences were
discarded. To remove Taq polymerase errors in cloned DBLα var tag sequences, a
neighbor-joining tree was constructed for each sample and sequences differing by less
than 3 nucleotides were condensed into a single consensus sequence. Thus, for each
sample only unique DBLα var tag haplotypes were analyzed.

Network analysis
A short region of var gene sequence within the DBLα domain, which we refer to as a
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“tag,” comprises three conserved homology blocks (HB3, HB5, and HB2) separated by
two highly variable regions (HVRs) (144). We identified HVRs using a sequence entropy
approach, modifying a previously published procedure (146) to accommodate ape
Laverania sequences. In order to extract highly variable sequence content for further
study, we identified and removed the three conserved homology blocks from the 3’ end,
middle, and 5’ end of each tag sequence. This was done by first aligning all sequences
first to HB3 without inserting any gaps mid-sequence (step 1), i.e., we required that all
sequences align at and only at HB3. Next, we calculated the Shannon entropy of the
aligned sequences at each position (step 2) and scanned from HB3 toward the center of
the tag to find the first position p at which entropy was greater than 2 bits (step 3) such
that each subsequent position also had entropy greater than 2 bits. Finally we retained
all sequences from p toward the center of the tag (step 4). Steps 1-4 were repeated for
HB2, thus removing low entropy homology blocks from the ends of each sequence.
Second, we removed conserved central sequence content, splitting the tag into two
HVRs. We repeated steps 1 and 2 with HB5. We then scanned from HB5 toward each
end of the tag, finding the first position p in each direction with entropy greater than 2
bits such that each subsequent position had entropy greater than 2 bits, and retained
everything from p toward the end of the tag. All steps are shown graphically in
Supplementary Fig. 7. The high entropy HVR between HB3 and HB5 is referred to as
the Left HVR and the high entropy HVR between HB5 and HB2 is referred to as the
Right HVR.
Two types of networks were created. First, networks of var sequences were
generated by assigning each HVR sequence to a node and placing a link between two
nodes when their corresponding sequences shared a block of length L or greater at the
amino acid level. L=7 for Left HVR and L=6 for Right HVR, based on null model
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calculations (146). Figures were produced using force-directed layouts in webweb
software v3.1 (http://danlarremore.com/webweb). Second, bipartite networks of both var
genes and their shared blocks were created by assigning each HVR sequence and each
shared block of length L or greater to a node, and placing a link between a sequence
node and a shared block node if the block is present in the sequence. These bipartite
networks are related to the other type of network via one-mode projection. Community
detection was performed using the biSBM method applied to bipartite networks of
sequences and their shared amino acid substrings (169).

k-mer stackup analysis
Within an amino acid sequence, we refer to any contiguous substring of length k amino
acids as a k-mer. All k-mers were extracted from all sequences, noting the starting
position (normalized to the total length of the sequence). For Supplementary Fig. 2A, all
k-mers from P. falciparum and P. reichenowi were sorted by their frequency of
appearance, and stacked histograms of their starting positions were created with 50
bins. For Supplementary Fig. 2B, all k-mers from each of P. falciparum, P. reichenowi, P.
gaboni, and P. billcollinsi were sorted by their presence across species, and stacked
histograms of their starting positions (relative to the species indicated at the top of each
plot) were created with 50 bins.

Bayesian k-mer analysis
A window of length k was scanned across each amino acid sequence from P. falciparum
and P. reichenowi monoinfections, extracting all length k substrings. Some substrings
appeared in sequences from both species, while others were species-specific. This
analysis, derived and developed in detail in Supplementary Text 1, estimates the overlap
99

in populations of tag sequences using Bayesian statistics to correctly extrapolate the
parameters of the conjugate prior distribution that characterizes the overlap from limited
sample data (170).
For this analysis, we examine 296 DBLα tag sequences from P. falciparum and
94 from P. reichenowi. Each sequence is a string of amino acids, so from a sequences
of length N, we can extract N−k+1 substrings (i.e. k-mers, or words) of length k. In what
follows, we use k=7 for all examples. (Other values of k may be used, and results do not
depend sensitively on moderate k; we tested k

[5, 15].) The 390 total sequences

comprise 45731 words for k = 7, but some words appear in multiple sequences; the total
number of unique words is 22431. This indicates that, on average, each word appears
approximately 2 times across all 390 sequences. In fact the distribution is highly
heterogeneous: 70% of words appear only once, 16% appear only twice, and 6% appear
only three times, meaning that 92% of words appear in only 1 to 3 of the total 390
sequences. This heterogeneity, depicted in Supplementary Figure 8, makes it difficult to
decide whether these two sets of sequences are drawn from distinct populations.
Some words are shared by both P. falciparum and P. reichenowi (8%), some are
unique to P. falciparum (65%) and the rest unique to P. reichenowi (27%). If only 8% of
(length 7) words are shared by both species, one might conclude that the populations of
words are well separated. However, owing to the massive diversity of words in both
species, and our small sample of sequence tags, this interpretation is incorrect. Instead
of calculating the overlap between species for our data set, we wish to use this data to
estimate the overlap for the global populations of P. falciparum and P. reichenowi.
Before the mathematical formulation, we advance the following helpful analogy,
by imagining each word as a biased coin. Suppose we have a large bag of coins and
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each coin has a biased probability of landing on heads. Further, imagine that the biases
are not all the same, but are instead drawn from some distribution. We wish to estimate
the distribution, so we take the coins, one by one, and flip them, writing down which coin
was flipped and whether it lands on heads or tails each time. However, for 70% of the
coins, we only get one flip. For 16% of the coins, we only get two flips, and for 6% of the
coins we only get three flips, etc. When estimating the distribution of p, we must take into
account the number of flips observed for each coin.
Given our small sample from the distribution, we wish to approximate the global
distribution of values of pi. This will tell us how much the populations overlap. Our data
consist of fi and ri, the numbers of observations of word i in P. falciparum and P.
reichenowi respectively. We model the assignment of each occurrence of word i to P.
reichenowi as an independent Bernoulli trial, with parameter pi. Let the set of pi be Beta
distributed with parameters α and β, where we use the Beta distribution because it is the
conjugate prior of the Bernoulli distribution. Then, the likelihood of observing data {xi},
given the parameters, is
!! !!!

!

! !! !, ! =
!!!

!!

Pr word is from !. !"#$ℎ!"#$% !! Pr (!! |!, !) !!!
!!!

which may be integrated using beta functions B to get
!

! !! !, ! =
!!!

! (!! + !, !! + !)
! (!, !)

Taking a log yields
!

log ! ( {!! }|!, !) =

log
!!!

! (!! + !, !! + !)
! (!, !)

This log-likelihood function is related to a solution to an analogous problem from the
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domain of probabilistic competition dynamics (170) in which two teams were competing
for points over the course of many competitions. We maximize it in MATLAB using the
fminsearch function, using the observed fi and ri values.

Pairwise distance analysis
Protein sequences were aligned pair-wise using MUSCLE v3.8.1 (127) and Hamming
distances (number of sites at which the two aligned sequences differ) were calculated
neglecting gaps at both ends of the alignment to adjust for variable sequence lengths.
Hamming distances were alternatively calculated by counting a contiguous block of gaps
as a single difference, with no qualitative difference in results.

Blocksharing
We quantified sequence conservation from one particular sequence to an ensemble of
others by scanning a window of length k across the particular sequence and computing
the fraction of sequences in the ensemble containing each k-mer or block. This produces
a measure of conservation between 0 and 1 in the frame of reference of the particular
sequence; Figure 4-1B shows this blocksharing for the DBLα domain of DD2var11
compared to the background of data (144); k=7.

CP group analysis
Var tag sequences can be classified according to the number of cysteine residues as
well as sequence content at defined “positions of limited variability (PoLV)”(152). In the
var sequence literature, these are referred to as Cys-PoLV groups, or simply CP groups.
We identified CP groups with a MATLAB script according to the following definitions:
Group 1: MFK* at PoLV, 2 cysteine residues; Group 2: *REY at PoLV2, 2 cysteine
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residues; Group 3: 2 cysteine residues, not group 1 or 2; Group 4: 4 cysteine residues,
not group 5; Group 5: *REY at PoLV2, 4 cysteine residues; Group 6: 1, 3, 5, or 6
cysteine residues. Histograms of cysteine counts and CP groups are shown in
Supplementary Fig. 6.

P. gaboni select whole genome amplification (SWGA)
DNA was extracted from two chimpanzee blood samples (SYpte37, SYptt75) identified
as P. gaboni single-species infections by single genome sequencing (Supplementary
Table 1) and subjected to select whole Plasmodium genome amplification as described
(39, 151). Briefly, total DNA (100 ng – 1 ug) was digested using the methylation
dependent restriction enzymes MspJI and FspEI in multiple replicates. The digestion
products were amplified using phi29 polymerase and one of two primer sets consisting
of 10 primers (8-12 nt in length each) designed to bind frequently and broadly to the P.
falciparum genome but only rarely to the chimpanzee genome (151). 50 ng of first round
product was re-amplified in a second reaction using the second primer set. Replicates
were pooled and a short insert library was constructed using the TruSeq DNA PCR-Free
Sample Preparation Kit (Illumina) and sequenced using a MiSeq Reagent Kit V2 (500cycles) (Illumina) to generate 250 bp paired end reads. Reads were mapped to the P.
falciparum 3D7 reference genome using Geneious (Biomatters Limited, Auckland, New
Zealand), and subjected to guided assembly using Velvet Columbus (114). For SYptt75,
contigs produced by Velvet were aligned to the reference and the resulting core P.
gaboni draft genome was iteratively corrected manually and using PAGIT v1.0 (81). All
reads from SYptt75 and SYpte37 were mapped to this draft reference and reads that
could not be mapped were assembled separately using Spades v3.1.1 (120).
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Putative var gene identification var domain analysis
Due to the hypervariability of var sequences, P. gaboni reads did not map to var gene
containing regions of the P. falciparum 3D7 reference genome, nor were var genes
readily identified in the SYptt75 core P. gaboni genome. A search for contigs containing
var-like sequence was therefore performed on unplaced SYptt75 and SYpte37 contigs
(produced by either Velvet or Spades in a reference-independent manner). Specifically,
tblastn and tblastx searches were performed using all P. gaboni unplaced contigs
against a database of available full-length P. falciparum 3D7 and P. reichenowi CDC1
var genes. Genes and ORFs were identified in the top hits manually and by Augustus
v2.5.5 gene prediction (123), and pblast searches using the resulting amino acid
sequences were again performed against the translated P. falciparum and P. reichenowi
var

gene

database.

Hits

were

then

(http://www.cbs.dtu.dk/services/VarDom/)

submitted
(144)

for

to

the

domain

VarDom

1.0

identification

server
and

classification.
The P. gaboni ortholog of PF3D7_0113800 was identified in the draft SY75
sequence by blast homology to PF3D7_0113800. Gene annotation was performed using
RATT (122) with manual correction.

Neighbor-joining tree construction
Protein sequence tags were aligned using MUSCLE v3.8.1 (127) and the phylogeny
were created using the neighbor joining (NJ) distance method, with Poisson distances,
as implemented in Seaview 4.4.0 (171).

DBLx identification and classification
DBLx domains were identified as those tags that (i) were less than 90 residues in length,
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and (ii) began with residues NI, DF, or DM. Those that began with residues NI were
further classified as DBLx1 and those that began with DF or DM as DBLx2. 100% of
DBLx sequences also featured a lysine residue (K) in the fourth position of the tag
instead of the DBLα arginine (R). Sequence logos are shown in Supplementary Fig. 3.
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5.1 Introduction
Population genomic analyses offer unprecedented capabilities to infer precise
evolutionary, ecological, epidemiological, and molecular processes and address major
outstanding questions in multiple microbiological fields (172, 173). These analyses of
many microbes are currently hindered by the practicalities of obtaining sufficient
numbers of genomes for analysis. Laboratory culture is the classical method to isolate a
target microbe from the other organisms and to obtain the appropriate samples for highthroughput sequencing, but many microbes cannot be cultured. Population genomics of
most microbial species will require a practical method to collect sufficient amounts of
target genomic DNA while limiting the amount of contaminating DNA (36).
Recently we developed selective whole genome amplification (SWGA), a culturefree technology that preferentially amplifies a specified target genome from total
genomic extracts derived from an environmental sample (39). SWGA removes the need
for ultra-deep sequencing or mechanical separation of target genomes from the
background sample. This is accomplished by choosing primers that anneal to DNA
sequence motifs that are common in the target genome but rare in the genomes of other
species present in the environmental sample. A previous difficulty in implementing
SWGA for many systems is a lack of automated, efficient, and reliable method to design
effective primer sets. The original method uses a series of Perl scripts to identify primers
that are common in the target genome and rare in the background sequences but
considerable user input is required to design sets of primers to be used for selective
amplification (39). Further, there is no way to quantitatively evaluate multiple primer sets
prior to empirical testing which is expensive in both time and money.
Here we present swga, a program that addresses previous issues with SWGA
primer design by computationally evaluating large numbers of primer sets on their
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potential to selectively amplify the genome of a target species. The swga program
identifies primers that should selectively amplify the target genome and rapidly evaluates
primer sets based on user-defined metrics. Many aspects of the program’s behavior,
including evaluation criteria, can be modified to suit the needs of specific projects. The
source

code,

download

links,

and

documentation

are

hosted

at

https://www.github.com/eclarke/swga. The program is licensed under the GNU Public
License (GPL) and is free to use and modify.

5.2 Methods
swga program overview
The swga program is designed to evaluate sets of primers on their potential to
selectively amplify the genome of a target species even when it is very rare in the
starting sample. The program can be divided into four steps (Figure 5-1): 1) counting
binding sites for all primers in the target and background genomes to identify primers; 2)
filtering primers based on parameters such as melting temperature and selectivity 3)
ranking sets of primers on multiple metrics that can be user-defined; 4) outputs and
visualization. Each part of the program can be run individually to optimize intermediate
results or as an integrated unit.
Step 1: Primer identification. The first part of the swga program, swga count, uses DSK(174) to identify all primers in the size range specified by parameters min_size
and max_size that exist in the target and background sequences. All primers that are
present in the target genome more times than specified by parameter min_fg_bind, and
fewer times in the background sequences than specified by parameter max_bg_bind
are saved in a local SQLite (175) database along with the number of times they appear
in the target and background genome sequence files.
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Figure 5-1. An overview of the swga workflow.
Step 2: Primer filters. The module swga filter ranks and filters primers by their
selectivity to the target genome and melting temperatures. This selectivity is calculated
by the ratio of binding sites in the foreground genome to binding sites in the background
genome. The most selective primers, by default no more than 200 (parameter
max_primers), that satisfy the calculated melting temperature parameters (min_tm and
max_tm) are saved along with the locations of their binding sites in the target sequence.
Step 3: Primer set evaluation. Evaluation of all potential sets of primers is
computationally intensive. The total number of possible primer combinations (n choose k
combinations) is 2.4*1016 using the default parameters. However, not all of the possible
combinations are compatible for SWGA. Primers are incompatible if they can form
109

heterodimers (i.e. they contain more consecutive complementary bases than specified
by parameter max_dimer_bp) or if one is a subsequence of the other. swga plots the
results of pairwise comparisons that establish mutual inter-compatibility as a
compatibility graph, where each primer is a vertex and compatibility is denoted edges
connecting primers. The problem of finding sets of entirely-compatible primers is thus
reduced to finding collections of vertices that have edges to every other vertex in the
collection (known as a clique in graph theory). We extend this by encoding the average
distance between primer binding sites on the background genome as a “weight” on each
vertex. This allows the program to prioritize cliques with higher total weights,
representing sets of primers that rarely bind the background genome.
The module swga find_sets uses a modified version of the program cliquer
(http://users.aalto.fi/~pat/cliquer.html) to evaluate cliques in the compatibility graph. The
branch-and-bound algorithm in cliquer limits the search space to cliques within desired
primer set size (min_size and max_size, weight (min_bg_bind_dist, and maximum
distance between target binding sites (max_fg_bind_dist. For primer sets that satisfy
these criteria, evaluative metrics including the average and maximum distance between
primer binding sites in the target genome and the evenness of the primer binding sites in
the target genome are calculated. Evenness is calculated on the Gini index (176), where
indices near 0 represent evenly spaced binding sites, and indices near 1 represent
uneven or “clumped” binding sites. These metrics are used in the default scoring
algorithm (fg_dist_mean * fg_dist_gini / bg_ratio), which identifies primer sets that
maximize selectivity and minimize the Gini index. Scoring algorithms can be altered by
the user via the score_expression parameter.
Step 4: Outputs and visualization. Because the total number of sets of size k in
the graph can be as high as (n^k)*k^2, and the wet-side procedure only needs one valid
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set, the program by default stops after it has found 500 valid sets (max_sets). The
saved primer sets can be evaluated by target selectivity of the primer set, the evenness
of primer binding sites in the target (Gini index) (176), the average and maximum
distance between binding sites in the target genome, and the average distance between
binding sites in the background. Metrics can be added and removed by users to
incorporate new criteria or alter the weight of the current criteria to the overall score. The
user can query the sets that score highest by any of the calculated metrics and export
the sets in a variety of common formats. Individual primers and primer sets can be
exported in tab-delimited format for use in downstream applications, and genomic
binding locations of the primers in a set can be exported in the common UCSC Genome
Browser Bed and BedGraph track format (177).

Empirical primer set evaluation
To evaluate the efficacy of the swga program to identify primer sets successfully enrich a
target genome from a complex genomic sample, we designed four primer sets to target
Wolbachia pipientis from infected Drosophila melanogaster. As the ideal parameters for
SWGA primer and primer set design have yet to be established, we designed sets with
“standard” (15-45 C) or “high” (35-55 C) melting temperature (Tm) ranges and chose the
set that either maximized the score or the set that minimized the Gini index within each
Tm range. The remaining parameters included: a set size of 2-12 primers, a max
consecutive bases for heterodimer and homodimer formation of 4, a minimum average
distance between binding sites in the background genome of 30,000, and a maximum
distance between any two binding sites in the target of 130,000. Instead of stopping at
500 sets (the default behavior), we let the program score ~1,000,000 sets in each Tm
range before the maximum scoring and minimum Gini index sets were chosen. These
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parameters were generally more permissive than the defaults in order to explore a
broader range of possible sets.
Each primer set was tested on pooled genomic DNA extracted from 10 flies,
which contained 4.7% Wolbachia DNA per ng. The pooled genomic DNA extract
provided sufficient starting material to test each primer set in addition to the previously
published SWGA primer set (39) in triplicate, while eliminating inter-fly variability in
Wolbachia infection levels. The pooled genomic extract was digested with NarI at 37 C
for 30 minutes to eliminate mitochondrial amplification as previously described prior to
being aliquoted (40 ng per reaction) for SWGA. SWGA replicates were performed using
the conditions previously described (39).
Amplified samples were purified using AmpureXP beads (Beckman Coulter),
prepared for Illumina sequencing using a modified Nextera Library Preparation Kit
protocol (178), and sequenced on an Illumina Miseq (150bp paired end). Adapter and
primer sequences were removed from the resulting reads using Cutadapt (179).
Trimmed

reads

were

first

mapped

to

the

Drosophila

genome

using

smalt

(http://sourceforge.net/projects/smalt/) and the unmapped read pairs were then mapped
to the Wolbachia genome. Breadth of coverage of the target genome (measured as
percentage of the genome with at least 10x coverage) and sequencing rarefaction
analyses were performed using R (180).

5.3 Results
Swga can rapidly identify target-biased primers, compatible primer sets, and evaluate
primer sets on their likelihood to selectively amplify the specified target genome. The
swga program was run four times using different parameter settings to characterize the
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effects of primer melting temperature and the selectivity score on selective amplification
and sequencing evenness.
Primer sets that satisfied the conditions of compatibility, minimum average
distance between background binding sites, and maximum distance between any
binding sites in the target were identified and evaluated from both the default and relax
melting temperature runs. The primer sets were then ranked according to the total
default score (see Methods) or according to the Gini index (176). We chose four primer
sets to test selective amplification of Wolbachia from fruit flies: one set using
min_tm=15C and max_tm=45C (Tm-) that had the best total score (henceforth referred
to as Tm/Score); one set using min_tm=15C and max_tm=45C that had the most even
distribution of primers (Tm/Gini); one set using min_tm=35C and max_tm=55C (Tm+)
that had the best total score (Tm+/Score); and one set using min_tm=35C and
max_tm=55C that had the most even distribution of primers (Tm+/Gini) (Table 5-1).

Table 5-1 Characteristics of primer sets chosen for selective whole genome
amplification of Wolbachia from infected Drosophila
Characteristics
Top Score;
Standard Tm
Top Gini;
Standard Tm
Top Gini; High Tm
Top Score; High
Tm
Leichty et al.

Score

Set
Size

bg_ratio

fg_max
_dist

fg_dist
_mean

fg_dist
_std

fg_dist
_gini

0.03560

9

97839

31147

5327

7004

0.654

0.05640
0.00405

7
2

65271
1732423

34697
112818

6853
13070

6996
15515

0.537
0.537

0.00033
0.01161

2
2

24253916
325172

128209
112839

12074
5305

18011
10052

0.660
0.712
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The efficacies of these four primer sets, as well as the previously published
primer set (39), in selectively amplifying Wolbachia genomes from infected fruit flies
were empirically evaluated using DNA extracted from a pool of 10 D. melanogaster. The
proportion of sequencing reads that were derived from Wolbachia DNA was at least
three times greater in all amplified samples than the sequencing reads from the
unamplified genomic extract (Figure 5-2). The previously published primer set (39) was
the least effective with 12.1%-27.7% of the sequencing reads mapping to the Wolbachia
genome while 59.9%-81.4% mapped to Drosophila. The primer sets with higher melting
temperatures (min_tm=35C and max_tm=55C) were considerably more effective at
amplifying Wolbachia DNA than all other primer sets, with as much as 77.8% of the
reads mapping to Wolbachia.
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Percent Unmapped
Percent Drosophila
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Leichty et al 1
Leichty et al 2
Leichty et al 3
Tm+/Gini 1
Tm+/Gini 2
Tm+/Gini 3
Tm+/Score 1
Tm+/Score 2
Tm+/Score 3
Tm/Gini 1
Tm/Gini 2
Tm/Gini 3
Tm/Score 1
Tm/Score 2
Tm/Score 3
Tm/Gini 20ng 1
Tm/Gini 20ng 2
Tm/Gini 20ng 3
Unamplified

0%

Percent Wolbachia

Figure 5-2. Percent of Wolbachia, Drosophila, and unmapped reads after SWGA
with swga derived or previously published primer sets.
The percent of reads that mapped to Wolbachia (black), Drosophila (blue), or neither
genome (gold), is shown for each primer set. Three replicates SWGA reactions (40 ng
total DNA per reaction) were performed for each primer set and the results are
presented separately for each. Additional triplicate SWGA reactions were performed
using the Tm/Gini set and 20 ng total DNA per reaction.
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The degree of enrichment of Wolbachia DNA after amplification did not
necessarily correlate with a decrease sequencing effort needed to achieve broad
coverage of the Wolbachia genome (Figure 5-3). For the Tm/Gini primer set, sequencing
effort required to achieve at least 10x coverage of 90% of the genome was reduced 10
fold relative to the unamplified control. On the other hand, rarefaction analysis indicated
that the higher melting temperature primer sets would never achieve 10x coverage of
even 10% of the Wolbachia genome (Figure 5-3). The lack of correlation was primarily
due to uneven amplification of across Wolbachia genome (Figure 5-4). Coverage
analysis of the higher melting temperature primer sets identified substantial enrichment
of a few short regions of the Wolbachia genome with little enrichment of the remaining
sequence (Figure 5-4). By contrast, amplification with the Tm/Gini primer set yielded
more even coverage across the genome, which was typically 10-100x better than that
obtained from the unamplified control (Figure 5-4).
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Figure 5-3. Relationship between sequencing effort and percent coverage of the
Wolbachia genome (at 10x read depth) after SWGA.
The total number of base pairs (in millions) sequenced is shown relative to the percent of
the Wolbachia genome covered at 10x read depth for the four swga derived primer sets
and the set previously published by Leichty et al. SWGA reactions were performed in
triplicate for each primer set using 40 ng of total DNA. An additional three reactions were
performed for the Tm/Gini set using 20 ng of total DNA.
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Figure 5-4. Normalized sequencing coverage across the Wolbachia genome after
SWGA.
Normalized coverage (1,000,000,000 * Fold Coverage / Total bp Sequenced) of the
Wolbachia genome is shown for each primer set. Three replicate SWGA amplifications
are shown in red, blue, and green. The black line in each plot window represents
coverage for an unamplified sample.
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The evenness of sequence coverage was weakly associated with primer density
among primer sets. For example, the primer sets chosen with standard melting
temperatures had more than twice as many total binding sites in the W. pipientis
genome than primer sets with high melting temperatures and the average sequencing
coverage was several orders of magnitude greater (Table 5-1). Within each primer set,
however, variation in primer density across the genome was not correlated with local
sequence coverage (Figure 5-5). For example, both primer sets chosen with high
melting temperatures had many 20,000 bp regions in which there were no primer binding
sites but these regions did not have lower sequence coverage than the regions that had
substantially higher densities of primer binding sites (>70, Figure 5-5).
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Figure 5-5. Relationship between primer binding site density and mean
sequencing coverage after SWGA.
Mean normalized coverage within a 20,000 bp sliding window is shown relative to the
number of binding sites within the same 20,000 bp window after SWGA. SWGA
reactions were performed in triplicate using either swga primer sets or the primer set
from Leichty et al. Coverage was calculated separately for each reaction and then
combined to generate the plot.
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5.4 Discussion
Microbial genomics is difficult when the genome of interest cannot be separated
from contaminating DNA. In these situations, the majority of sequencing reads may be
derived from contaminating DNA, increasing the sequencing effort required to get
substantial coverage of the genome of interest. SWGA overcomes this by selectively
enriching for a target genome from a complex DNA mixture (39), however this method
requires the computationally difficult identification and validation of selective primer sets.
Swga can identify and quantitatively evaluate millions of primers and primer sets to
facilitate SWGA primer design. Swga quickly and efficiently identified sets for the
amplification of Wolbachia from infected Drosophila. Moreover, at least one of the
chosen sets performed significantly better than previously published (39), hand picked,
primers.
The swga program identifies primers that are common in the target species and
rare in the background and rapidly evaluates primer sets on their potential to amplify the
target genome. Computational evaluation of thousands of primer sets provides a major
advance over the previous implementation of SWGA in which the user hand-assembled
a small number of primer sets (39). In the current version of swga, primer sets are
evaluated on multiple criteria that are logically associated with phi29 amplification. The
swga program can also be altered by the end user to add new evaluative criteria as
correlations between amplification and primer set characteristics become available.
All of the primer sets chosen by the swga program and by human users (39)
selectively amplified W. pipientis DNA from infected fruit flies, such that the proportion of
sequencing reads that mapped to Wolbachia was at least 3 times greater than reads
from the unamplified sample. The criteria used to choose the Tm/Score primer set were
chosen to maximize the number of binding sites in the target genome and minimize the
121

number of binding sites in the background, while the evenness of primers across the
target genome was not emphasized, which were based on the same principles used by
Leichty and Brisson (2014). As may be expected, sequencing coverage after
amplification with either of these primer sets was uneven (Figure 5-4). However, the
decrease in sequencing effort required to yield broad coverage of the Wolbachia
genome was substantially lower after amplification with the primers chosen by the swga
program (Figure 5-1).
The swga program efficiently chooses primer sets to selectively amplify target
microbial genomes without prior culture or molecular separation. However, it is unlikely
that the currently implemented criteria are ideal for identifying the best primer sets to
evenly amplify a target genome. The criteria used to choose primer sets could be
improved by a better understanding of the biochemistry of the phi29 enzyme and by a
careful evaluation of primer set characteristics against amplification and coverage
evenness across many different primer sets. Sequence coverage and primer
characteristics from both successful and unsuccessful SWGA amplifications could allow
an empirical investigation of primer set characteristics that result in strong and even
amplification. These criteria could be then incorporated into the swga program during
future updates.
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CHAPTER 6 – Summary and Future Directions

6.1 Summary
African great apes are infected with a plethora of Plasmodium species including the
closest relatives and direct ancestors of P. falciparum (26, 110). Studying these
parasites can provide insights into the evolutionary history of this important pathogen
and the genetic changes required to colonize humans. Chapter two of this dissertation
shows that ape Laverania parasites do not recurrently infect humans, suggesting that
there exists one or more blocks to cross-species transmission among these parasites.
Chapters three and four describe the first comparative genomic analyses of both close
and distant ape relatives of P. falciparum. These analyses identify features that are
shared across the Laverania subgenus as well as some that are unique to the ancestry
of P. falciparum. Chapter five provides a computational framework for efficient SWGA
primer design that makes this genome enrichment strategy more accessible and easier
to implement for any set of target and non-target genomes. Together, this dissertation
offers the first genome wide insights into the Laverania subgenus and provides a
foundation for future work. Here I propose future studies that may further elucidate the
basis of Laverania host-specificity and the evolutionary steps that gave rise to P.
falciparum.
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6.2 Future Directions
Identifying barriers to cross species transmission
Chapter two of this dissertation describes the first large-scale screen for ape Laverania
infections in humans in West Central Africa. While this study focused on populations
within Cameroon, an additional study found no evidence of Laverania infections in
forest-dwelling humans from Gabon (181). These data support the hypothesis that
human infections with ape Laverania parasites are incredibly rare (26). Importantly,
these studies focused solely on blood samples. It is possible that humans are exposed
to ape Laverania parasites, but that these parasites cannot establish a blood stage
infection and are therefore missed in blood based screens. Additional screening studies
may allow us to determine if humans are exposed to ape Laverania parasites and if
these parasites can establish pre-erythrocytic stage infections. Future studies should
include of mosquito based screens, to determine whether ape Laverania infected
mosquitoes feed on humans, and non-invasive pre-erythrocytic stage screens, to identify
liver stage infections that fail to progress to the blood.
Mosquitoes are essential to the transmission of all Plasmodium parasites and
may therefore play an important role in facilitating or preventing cross species
transmission (182, 183). While the major vectors of human malaria in West Africa are
well characterized (184-186), little is known about the mosquitoes that transmit malaria
between wild African apes. Mosquito studies can answer two important questions. First,
blood meal screenings of mosquitoes caught near great apes populations will help
pinpoint mosquito species that regularly feed on these species. Second, screens for
Plasmodium infections in these mosquito populations will identify which species act as
competent vectors for ape Laverania parasites. Once potential ape Laverania vectors
have been identified, mosquito catches in human settlements, especially those that are
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located within the home range of wild ape populations, will allow us to determine if
certain mosquito species may act as vectors for cross species between apes and
humans.
While the proposed mosquito studies will be useful in determining whether
mosquitoes serve as a block to Laverania cross species transmission, it is important to
recognize the technical challenges associated with mosquito collection. Traps typically
rely on CO2 or light to attract mosquitoes (187). CO2 traps, while more effective (187),
require a source of CO2, which may be difficult to come by in more remote settings. The
latter traps attract a wide variety of insects, and their contents must be sorted to remove
unwanted species (DE Loy, unpublished). As it is likely that the proportion of both
Laverania infected mosquitoes and ape blood fed mosquitoes is very small, these
studies may require large numbers of mosquitoes to identify species that regularly feed
on apes and those that serve as vectors for ape malaria. Some of these obstacles may
be overcome by performing studies at chimpanzee sanctuaries. Sanctuaries provide a
more controlled environment with fixed and accessible nesting sites that should allow the
placement of more permanent traps. However, these sanctuaries may not be completely
representative of natural ape habitats, and field studies will be necessary to ensure that
these sanctuary based studies do not introduce unforeseen bias.
If humans are exposed to ape Laverania infected mosquitoes, it is possible that
these parasites establish a liver stage infection but are unable to progress to the blood
stage. Recent studies of the rodent parasite P. yoelli have shown that parasite DNA from
pre-erythrocytic stage infections can be detected in fecal samples (188). If this holds true
for the Laverania parasites, fecal PCR could be used as a non-invasive screening tool
for liver stage infections in humans. If ape Laverania parasite DNA can be identified in
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human populations, it would indicate that humans are exposed to ape Laverania and
potentially develop liver stage infections.
Screening for antibodies to ape Laverania antigens could provide another means
of detecting liver or aborted blood stage infections. Protein microarrays are now
commonly used in studies of P. falciparum to compare the antibody profiles of exposed
and naïve individuals (189). A similar approach could be used to screen for Laverania
exposure, using protein sequences from the P. gaboni and P. reichenowi genomes. If
such a study were to be undertaken, it would be important to differentiate true Laverania
exposure from cross-reactivity to the antigens of endemic human Plasmodium species.
This could be achieved by comparing the antibody profiles of individuals living near
infected ape habitats with those from other human malaria endemic regions. The fecal
DNA and antibody-based studies described here would complement mosquito studies.
They would provide evidence for human exposure to ape Laverania, indicating that at
least some ape Laverania vectors feed on both humans and apes.
While the studies I have proposed here may identify specific stages at which
cross species transmission is prevented, it is reasonable to expect that the lack of
zoonotic Laverania infections is multifactorial. This appears to be the case for P.
falciparum infections of chimpanzees. While these infections have never been detected
in wild living apes, our lab and others have identified multiple instances of reverse
zoonosis in sanctuary chimpanzees (unpublished observation). This is not unexpected.
Sanctuary chimpanzees are likely exposed to P. falciparum much more frequently than
wild populations. Even in sanctuaries, however P. falciparum infections represent a very
small proportion of the total malaria burden. These data would therefore suggest that,
while a lack of exposure to infected mosquitoes limits cross species transmission,
species-specific interactions at later stages of parasite development are also important.
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Population genetics of ape Laverania parasites
While this dissertation provides the first genomic level analysis of close and distant
chimpanzee relatives of P. falciparum, additional ape Laverania population genomic
studies will provide further insight into the evolutionary history of P. falciparum. Current
ape Laverania genomic studies have focused solely on chimpanzee parasites (69).
These studies cannot differentiate between evolutionary events that occurred during the
emergence of P. falciparum and those that were present in P. praefalciparum. The
identification of adaptive changes that allowed P. falciparum to colonize humans
requires a direct comparison of P. falciparum to its gorilla ancestor. Blood samples from
gorillas are extremely difficult to obtain due to the endangered status of these apes and
the low numbers of gorillas in sanctuaries in West Africa. Thus, obtaining complete
genomes of P. praefalciparum and other gorilla parasites will require the development of
new selective enrichment strategies from non-invasively collected samples. One
unexplored source of Laverania infected gorilla blood are sanguinivorus insects. While
many such insects would not be susceptible to Laverania infection, those caught soon
after feeding may still contain intact Laverania parasites in the blood meal. Experiments
to determine if these blood meals can serve as sources of full length Laverania genomes
are ongoing (100).
Genome-wide comparisons of P. falciparum, P. reichenowi and P. gaboni
identified the first evidence of horizontal gene transfer between two Plasmodium
species. Strikingly, the horizontally transferred segment contains two essential invasion
genes, RH5 and CyRPA, which define the 3’ and 5’ ends of the segment. The
maintenance and complete fixation of P. adleri derived alleles of both of these genes in
P. praefalciparum suggests that this horizontally transferred segment was selected for. It
is also possible, however, that this region was fixed in P. praefalciparum due to random
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drift. These two phenomenon may be differentiated through genomewide comparisons of
multiple P. praefalciparum isolates. Fixation due to recent selection should produce
signatures of a recent selective sweep, a reduction in nucleotide diversity in the genes
surrounding the region under selection. Fixation due to random drift, on the other hand,
would not be expected to yield this phenomenon. Evidence of selection for the
transferred alleles would support our hypothesis that the P. adleri derived RH5 and
CyRPA provided a fitness advantage for P. praefalciparum, and that this HGT event may
have predisposed P. praefalciparum to infect humans.
The identification of a horizontal gene transfer event between two distinct
Plasmodium species suggests a potential novel mechanism for genetic innovation in
these parasites. This gene transfer event may have occurred by one of two
mechanisms: sexual recombination followed by successive backcrossing, or asexual
DNA transfer between two parasites. DNA transfer between Plasmodium infected
erythrocytes is known to occur in cultures of P. falciparum. Recent work by RegevRudzki et al has shown that exosome-like vesicles can transport genomic or plasmid
DNA between infected erythrocytes and that transferred DNA can be expressed by the
recipient parasite (97). It is therefore possible DNA could be exchanged between distinct
Plasmodium species during co-infection. It seems less likely that this region was
exchanged via sexual recombination and subsequent backcrossing. Horizontal gene
transfer by this mechanism would require an F1 generation parasite that was viable
despite having inherited genes from two divergent, non-recombining, species. Moreover,
it would require that all the offspring of subsequent backcrosses remained viable.
Nevertheless, neither mechanism can be ruled out, as we cannot estimate the
probability or frequency of HGT from a single ancestral event. Future population
genomic studies of Plasmodium species may elucidate this by searching for inter128

species horizontal gene transfer events, especially in populations where mixed infections
are common.
In their comparison of P. falciparum to P. reichenowi CDC1, Otto et al emphasize
the results of screens for adaptive selection such as the McDonald-Kreitman (MK) test
(69). The MK test compares the ratio of non-synonymous to synonymous fixed
differences (between species, Dn/Ds) to the ratio of non-synonymous to synonymous
polymorphisms (within species, Pn/Ps) (190). An excess in non-synonymous fixed
differences between species (Dn/Ds > Pn/Ps) is suggestive of adaptive evolution, while
equal ratios of Dn/Ds and Pn/Ps are suggestive of neutral evolution (190). Surprisingly,
when we applied genome-wide MK tests to the a set of global P. falciparum isolates and
P. reichenowi SY57, few genes were found to be significant after controlling for multiple
hypothesis testing, and no genes showed significant evidence of adaptive selection.
Instead, we observed an excess of non-synonymous polymorphism within the global
population of P. falciparum. It has previously been proposed that this excess in nonsynonymous polymorphism is derived from the extreme A-T richness of the P.
falciparum genome (191), although this has been disputed (192). Another possibility is
that the excess in nonsynonmyous polymorphism is the result of a recent P. falciparum
population bottleneck (190, 193). Sequencing additional P. gaboni or P. reichenowi
genomes will help elucidate the cause of the observed excess of non-synonymous
polymorphism in P. falciparum. If the excess of non-synonymous polymorphism were
due to high A-T content, we would expect to observe a similar excess in Pn in all
Laverania species. If, on the other hand, this excess were related to the recent
population bottleneck in P. falciparum we would not expect to see an excess in nonsynonymous polymorphism in other Laverania species. Identifying the cause of this
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excess may enable us to control for it in future analyses, increasing the power of
evolutionary tests to detect adaptive selective in P. falciparum.
The comparisons of P. falciparum var genes with var-like genes from other
Laverania species demonstrate the ancient origins of this gene family. Our current
analyses are, however, limited in their reliance on P. falciparum var sequences to query
the Laverania genomes and to guide the design of var-specific primers. It is therefore
possible that additional var-like genes or var-gene domains, such as CIDR domains,
were missed because they are divergent from those found in P. falciparum. Additional
whole genome sequencing and assembly may help to elucidate by yielding more
complete var-like gene sequences.

In vitro studies
Comparative analyses of P. falciparum and ape Laverania parasites have identified
specific genes that may be important for adaptation to humans. While var gene analyses
across the Laverania subgenus indicate that the precursors of the var family existed in
the Laverania ancestor, key differences exist between P. falciparum var genes and varlike genes in the more distantly related Laverania parasite, P. gaboni. One important
distinction is the lack of CIDR domains in P. gaboni. These domains have been shown to
be important for binding to host receptors (194, 195), and their absence in P. gaboni
may indicate that the binding and sequestration properties of Laverania parasites have
continued to evolve since the radiation of the subgenus. While the current P. gaboni
assembly lacks full length var genes, this can be remedied by additional sequencing
using long read high throughput technologies (196, 197). Binding studies, using P.
falciparum parasites that express full length ape Laverania var genes, will help
determine if var gene function is conserved across the subgenus and, if so, whether the
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var genes of divergent ape Laverania bind the similar targets as their P. falciparum
orthologues.
As the extant P. falciparum RH5 allele was derived via horizontal gene transfer,
binding studies to determine the species specificity of the RH5-basigin interaction are of
particular interest. While previous studies have shown that the interaction between RH5
and basigin limits the host tropism of P. falciparum (102), it is unclear if this is the case
for other Laverania parasites. Unfortunately, the fixation of the P. adleri derived RH5
allele in P. praefalciparum precludes a direct comparison of the binding properties of
pre- and post-HGT RH5. Comparisons can, however, be made to other RH5 alleles.
While in vitro binding assays can identify differences in the binding interactions of
various RH5-basigin combinations (102), a more direct method of determining the effect
of this interaction on invasion would be erythrocyte invasion assays using transgenic
parasites expressing Laverania RH5. A lack of invasion by some or all Laverania RH5
transgenic strains would be strongly support the role of the RH5-basigin interaction in
determining Laverania host specificity.
In summary, this dissertation provides a foundation for future studies of the ape
Laverania subgenus. While these parasites are endemic and present at high levels in
wild African apes (26), they are not a source of recurrent human infections. Comparative
genomics of close and distant relatives of P. falciparum has identified features that are
shared across the subgenus, as well as those that are unique to the ancestry of P.
falciparum. Additional studies are required to further our understanding of the barriers to
cross species transmission and to perform direct comparisons of P. falciparum to its
closest ancestor, P. praefalciparum. These studies will not only expand our
understanding of the evolutionary origins of P. falciparum, but may also identify
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previously unknown host-parasite interactions that can serve as a basis for future
therapeutic interventions.
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